data_1kcn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1kcn _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 58.2 m . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.21 146.42 69.76 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.193 1.929 . . . . 0.0 111.722 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.17 -41.02 59.89 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.57 1.548 . . . . 0.0 112.997 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.47 -38.01 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.515 1.526 . . . . 0.0 112.853 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.5 m -60.33 -36.59 78.3 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.325 1.05 . . . . 0.0 112.415 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 N--CA 1.453 -0.303 0 C-N-CA 124.132 0.973 . . . . 0.0 109.485 -177.875 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.46 159.27 53.2 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.934 2.423 . . . . 0.0 110.664 172.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -51.28 -41.91 60.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.989 1.315 . . . . 0.0 112.735 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.8 t -51.92 -38.77 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.343 1.457 . . . . 0.0 112.191 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.0 m -55.53 -38.71 69.6 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.545 0.738 . . . . 0.0 111.836 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -89.45 -52.63 4.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.81 0.844 . . . . 0.0 109.209 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 124.631 1.172 . . . . 0.0 107.97 176.897 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.5 m . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -58.89 149.54 77.92 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.774 2.316 . . . . 0.0 112.166 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.0 -42.95 60.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.899 1.28 . . . . 0.0 113.136 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -53.33 -31.46 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.706 1.202 . . . . 0.0 112.907 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.6 m -55.04 -43.23 73.57 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.073 0.549 . . . . 0.0 111.072 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 . . . . . 0 N--CA 1.454 -0.228 0 C-N-CA 124.539 1.136 . . . . 0.0 109.735 -175.212 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -58.02 151.88 55.03 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.409 2.073 . . . . 0.0 112.468 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -52.49 -40.38 62.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.713 1.205 . . . . 0.0 112.98 -172.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -49.17 -35.83 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.647 1.579 . . . . 0.0 112.423 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -52.75 -47.1 67.66 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.15 0.98 . . . . 0.0 111.066 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -89.74 -49.83 6.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.062 0.945 . . . . 0.0 110.816 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 m . . . . . 0 CA--C 1.533 0.308 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -176.043 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.19 162.8 41.34 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.314 2.676 . . . . 0.0 110.684 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.28 -37.64 56.09 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.935 1.294 . . . . 0.0 112.754 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.0 t -51.33 -40.33 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.328 1.451 . . . . 0.0 111.901 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.4 m -59.51 -36.77 76.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.552 0.741 . . . . 0.0 111.955 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 . . . . . 0 N--CA 1.454 -0.234 0 C-N-CA 123.734 0.814 . . . . 0.0 109.832 -176.187 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.3 m . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -49.95 138.24 35.14 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.658 2.905 . . . . 0.0 113.497 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.51 -39.7 73.76 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.081 0.952 . . . . 0.0 111.813 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.21 -38.5 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.644 1.578 . . . . 0.0 111.448 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.4 m -55.31 -36.38 66.14 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.645 0.778 . . . . 0.0 112.249 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -89.48 -50.77 5.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.913 0.885 . . . . 0.0 109.408 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.454 -0.247 0 C-N-CA 124.55 1.14 . . . . 0.0 108.873 177.285 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.2 m . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.4 158.64 51.59 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.843 2.362 . . . . 0.0 111.763 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.97 -41.45 62.13 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.156 1.382 . . . . 0.0 112.581 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.5 t -48.77 -47.74 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.981 1.312 . . . . 0.0 111.317 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.6 m -63.0 -22.43 66.85 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.536 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 m . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.77 156.84 64.1 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.166 2.578 . . . . 0.0 111.937 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.52 -21.99 66.84 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.799 1.239 . . . . 0.0 113.811 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -53.4 -36.23 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.562 0.745 . . . . 0.0 111.504 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.9 m -74.73 -26.19 59.63 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.567 0.747 . . . . 0.0 112.91 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -89.43 -54.15 4.22 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.416 0.553 . . . . 0.0 109.941 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 125.394 1.477 . . . . 0.0 110.737 -178.263 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.83 157.97 53.5 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.078 2.518 . . . . 0.0 112.009 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.24 -36.42 66.02 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.219 1.407 . . . . 0.0 113.392 -173.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.8 p -52.32 -39.39 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.299 1.04 . . . . 0.0 112.631 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.2 m -67.66 -27.99 67.33 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 N--CA 1.454 -0.25 0 C-N-CA 123.498 0.719 . . . . 0.0 109.141 -179.047 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.7 m . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.35 165.61 32.17 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.468 2.779 . . . . 0.0 112.198 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -52.64 -45.53 66.72 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.673 1.189 . . . . 0.0 111.823 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.05 -40.82 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 111.576 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.8 m -63.75 -26.22 68.54 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -89.52 -51.96 5.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.576 0.75 . . . . 0.0 109.019 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 CA--C 1.533 0.314 0 C-N-CA 125.046 1.338 . . . . 0.0 108.089 178.017 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.01 153.4 20.79 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.906 2.404 . . . . 0.0 112.049 169.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.93 -37.59 45.12 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.914 1.286 . . . . 0.0 113.623 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.77 -31.17 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.199 1.0 . . . . 0.0 112.56 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.3 m -74.19 10.54 1.21 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.096 0.958 . . . . 0.0 113.053 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.341 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.3 m . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.1 127.41 12.67 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.515 2.81 . . . . 0.0 113.174 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -48.35 -44.24 34.19 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.389 1.475 . . . . 0.0 112.973 -171.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 p -50.7 -34.39 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.964 1.306 . . . . 0.0 112.924 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.8 m -64.42 -29.97 71.01 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -89.8 -54.66 3.95 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.866 0.866 . . . . 0.0 109.011 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.532 0.28 0 C-N-CA 124.855 1.262 . . . . 0.0 108.202 178.556 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.0 m . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.14 153.21 75.33 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.375 2.05 . . . . 0.0 111.296 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.18 -38.23 38.75 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.339 1.456 . . . . 0.0 112.728 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.8 t -51.01 -37.91 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.317 1.447 . . . . 0.0 112.086 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 83.1 m -56.07 -42.06 76.08 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.075 0.95 . . . . 0.0 111.504 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 N--CA 1.454 -0.268 0 C-N-CA 124.035 0.934 . . . . 0.0 109.823 -173.735 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 63.2 m . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.06 143.7 13.55 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.822 3.015 . . . . 0.0 113.524 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.0 -39.52 72.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.731 0.812 . . . . 0.0 111.776 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 p -56.74 -27.24 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.949 1.3 . . . . 0.0 112.807 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -51.78 -46.68 64.25 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.226 0.611 . . . . 0.0 110.358 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -89.78 -47.96 7.56 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.795 1.238 . . . . 0.0 109.478 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.534 0.336 0 C-N-CA 124.707 1.203 . . . . 0.0 108.04 176.867 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.1 m . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -52.18 140.99 50.11 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.344 2.696 . . . . 0.0 113.857 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.0 -35.09 61.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.13 1.372 . . . . 0.0 112.952 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.84 -30.46 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.939 0.896 . . . . 0.0 112.133 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.5 m -77.17 24.06 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.508 0.723 . . . . 0.0 112.736 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.343 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -62.57 151.5 82.94 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.424 2.083 . . . . 0.0 110.948 170.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -47.59 -40.96 20.66 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.116 1.766 . . . . 0.0 113.52 -173.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 p -46.12 -39.79 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.592 1.557 . . . . 0.0 112.791 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.7 m -60.17 -36.06 76.73 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.983 0.913 . . . . 0.0 112.14 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -89.28 -49.61 6.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.798 0.839 . . . . 0.0 110.46 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.3 m . . . . . 0 CA--C 1.533 0.326 0 CA-C-N 117.799 0.272 . . . . 0.0 111.613 -178.432 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.4 m . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -54.23 154.03 19.9 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.893 3.062 . . . . 0.0 113.855 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.35 -42.86 74.45 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.156 1.383 . . . . 0.0 113.039 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.48 -34.33 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.468 1.107 . . . . 0.0 112.846 -175.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.0 m -65.71 -22.73 66.64 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.249 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 119.32 -0.371 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -53.45 151.96 22.12 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.977 3.118 . . . . 0.0 113.893 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -55.4 -43.58 75.35 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.85 1.26 . . . . 0.0 112.804 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -55.13 -32.81 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.704 1.202 . . . . 0.0 112.98 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.2 m -64.96 -25.86 68.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.215 0.462 . . . . 0.0 112.241 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -89.56 -52.85 4.8 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 CA--C 1.533 0.3 0 C-N-CA 124.78 1.232 . . . . 0.0 108.151 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 78.9 m . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.76 154.16 62.64 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.836 2.358 . . . . 0.0 112.313 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.19 -41.48 68.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.679 1.192 . . . . 0.0 113.176 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -51.12 -34.38 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.915 1.286 . . . . 0.0 112.545 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.9 m -56.21 -43.49 78.59 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.036 0.934 . . . . 0.0 111.175 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 124.561 1.144 . . . . 0.0 110.034 -173.678 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.16 159.26 52.99 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.81 2.34 . . . . 0.0 112.31 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -52.42 -36.27 53.9 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.241 1.416 . . . . 0.0 112.239 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.1 t -46.86 -40.45 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.55 1.54 . . . . 0.0 111.596 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.8 m -55.34 -45.56 76.4 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.103 0.961 . . . . 0.0 111.709 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -89.63 -37.48 14.61 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.376 1.07 . . . . 0.0 110.945 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.8 t . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 123.969 0.907 . . . . 0.0 109.681 174.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.0 m . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -58.58 152.39 55.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.423 2.748 . . . . 0.0 114.22 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.23 76.73 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.296 1.038 . . . . 0.0 111.036 173.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -51.15 -44.01 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.118 1.367 . . . . 0.0 110.769 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 54.1 m -65.69 -20.02 66.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 . . . . . 0 CA--C 1.531 0.217 0 CA-C-N 118.452 0.569 . . . . 0.0 110.94 176.216 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.8 m . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.73 164.44 13.67 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.966 2.444 . . . . 0.0 113.02 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -55.68 -31.36 62.33 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.039 1.336 . . . . 0.0 113.24 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.8 p -49.26 -41.44 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.095 1.358 . . . . 0.0 112.055 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.3 m -61.07 -34.33 74.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.483 1.113 . . . . 0.0 111.868 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -91.97 -48.53 6.71 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.299 1.039 . . . . 0.0 110.505 -170.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.533 0.325 0 C-N-CA 122.871 0.468 . . . . 0.0 110.942 179.422 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 63.3 m . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.64 149.63 79.29 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.83 2.354 . . . . 0.0 111.578 -177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.76 -42.71 65.22 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.284 1.434 . . . . 0.0 112.753 -174.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -54.56 -34.38 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.462 1.105 . . . . 0.0 112.699 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.2 m -65.9 -26.42 67.61 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 174.485 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -55.97 161.25 8.78 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.293 2.662 . . . . 0.0 114.126 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.34 -39.58 70.19 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.08 1.352 . . . . 0.0 113.452 -172.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -53.47 -31.52 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.018 1.327 . . . . 0.0 112.983 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.0 m -52.66 -46.45 67.18 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.22 1.008 . . . . 0.0 111.14 177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.36 -47.4 7.49 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.906 1.283 . . . . 0.0 108.867 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 124.931 1.292 . . . . 0.0 107.967 176.548 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 m . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.93 163.87 35.85 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.852 2.368 . . . . 0.0 112.133 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.52 -39.9 71.11 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.661 1.184 . . . . 0.0 111.746 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.2 t -51.87 -47.49 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.459 1.103 . . . . 0.0 110.397 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 m -66.65 -16.64 64.35 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 . . . . . 0 CA--C 1.533 0.304 0 C-N-CA 123.701 0.801 . . . . 0.0 112.144 174.516 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.9 m . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.08 152.19 38.63 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.319 2.679 . . . . 0.0 113.707 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -59.06 -22.52 60.88 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.653 1.181 . . . . 0.0 112.596 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -52.13 -46.22 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.832 1.253 . . . . 0.0 110.703 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.7 m -66.22 -29.56 69.84 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.362 0.665 . . . . 0.0 112.496 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -89.71 -35.15 15.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.782 0.833 . . . . 0.0 111.26 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 124.71 1.204 . . . . 0.0 110.485 -177.876 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.1 m . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.56 143.39 68.21 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.519 2.812 . . . . 0.0 114.081 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.02 -39.73 82.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.692 1.197 . . . . 0.0 112.373 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.52 -32.16 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.714 1.206 . . . . 0.0 112.361 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -61.4 -34.49 75.45 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.794 0.438 . . . . 0.0 111.95 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 N--CA 1.455 -0.19 0 C-N-CA 123.437 0.695 . . . . 0.0 109.406 -177.559 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 m . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -51.75 162.95 1.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 124.218 3.278 . . . . 0.0 114.243 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.87 -47.8 76.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.959 1.304 . . . . 0.0 112.306 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -56.4 -28.73 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.758 1.223 . . . . 0.0 112.955 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -58.78 -35.45 72.83 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.289 0.635 . . . . 0.0 111.532 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -89.36 -58.07 2.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.916 0.887 . . . . 0.0 109.043 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.5 m . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 121.668 0.746 . . . . 0.0 109.084 176.149 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -55.08 136.9 75.08 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.796 2.331 . . . . 0.0 112.918 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.02 -41.67 59.96 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.327 1.451 . . . . 0.0 113.193 -173.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.5 p -51.93 -34.37 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.812 1.245 . . . . 0.0 112.77 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.6 m -59.87 -36.04 76.08 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.199 0.6 . . . . 0.0 112.003 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.523 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.54 167.42 24.21 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.931 2.421 . . . . 0.0 111.013 172.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -52.27 -40.83 62.25 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.995 1.318 . . . . 0.0 112.375 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -47.29 -45.14 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.959 1.703 . . . . 0.0 111.917 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.3 m -61.28 -35.25 76.79 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.068 0.947 . . . . 0.0 112.429 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -89.71 -47.83 7.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.697 0.799 . . . . 0.0 110.909 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 CA--C 1.53 0.192 0 C-N-CA 124.858 1.263 . . . . 0.0 109.607 -177.574 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.9 m . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.92 155.04 35.04 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.351 2.7 . . . . 0.0 113.685 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.01 -33.8 67.54 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.961 1.304 . . . . 0.0 112.797 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.66 -38.35 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.293 1.437 . . . . 0.0 111.925 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 m -64.3 -31.99 73.41 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 CA--C 1.531 0.223 0 C-N-CA 123.232 0.613 . . . . 0.0 110.049 -176.69 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.9 m . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.03 167.95 25.9 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.319 2.679 . . . . 0.0 111.859 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -54.21 -37.85 65.01 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.844 1.258 . . . . 0.0 111.805 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.4 t -54.51 -43.47 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.035 1.334 . . . . 0.0 111.006 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.4 m -71.58 -21.12 61.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.72 -48.14 7.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.286 0.634 . . . . 0.0 110.555 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.9 m . . . . . 0 CA--C 1.53 0.205 0 C-N-CA 124.923 1.289 . . . . 0.0 109.495 -178.821 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.0 m . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.68 144.02 44.5 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.253 2.636 . . . . 0.0 112.798 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.49 -40.93 65.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.385 1.074 . . . . 0.0 112.478 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -52.93 -31.71 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.091 1.357 . . . . 0.0 112.72 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.4 m -58.0 -44.75 87.38 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.359 1.064 . . . . 0.0 111.034 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 123.953 0.901 . . . . 0.0 110.28 -174.21 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.7 m . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -49.84 145.18 18.96 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.543 2.829 . . . . 0.0 113.744 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.59 -38.71 67.05 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.049 0.94 . . . . 0.0 111.412 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.9 t -51.33 -35.35 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.832 1.653 . . . . 0.0 112.076 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.9 m -50.96 -48.2 61.05 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.814 0.846 . . . . 0.0 110.785 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -89.58 -48.6 7.19 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.299 1.04 . . . . 0.0 109.593 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 124.747 1.219 . . . . 0.0 107.891 175.625 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.8 m . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -65.87 141.62 65.85 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.258 1.972 . . . . 0.0 111.743 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.56 53.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.672 1.589 . . . . 0.0 113.211 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.96 -31.92 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.719 1.207 . . . . 0.0 112.598 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.6 m -64.2 -36.77 85.15 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.085 0.554 . . . . 0.0 111.959 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 123.805 0.842 . . . . 0.0 109.765 -177.255 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.08 163.86 37.77 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.383 2.722 . . . . 0.0 111.665 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.29 -44.57 54.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.78 1.632 . . . . 0.0 112.768 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.07 -31.4 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.807 1.243 . . . . 0.0 112.917 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.1 m -57.65 -42.72 84.02 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.152 0.581 . . . . 0.0 111.197 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -89.47 -48.77 7.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.956 0.902 . . . . 0.0 110.485 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.4 t . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 123.526 0.73 . . . . 0.0 110.461 -178.01 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.9 m . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.72 140.65 56.87 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.155 1.903 . . . . 0.0 112.018 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.65 -26.62 14.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.666 1.987 . . . . 0.0 114.483 -172.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.7 p -52.42 -32.21 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.81 0.844 . . . . 0.0 111.953 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.49 12.01 15.56 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 . . . . . 0 C--N 1.342 0.279 0 C-N-CA 126.084 1.754 . . . . 0.0 109.186 -177.818 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 92.4 m . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -52.72 147.47 31.36 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.353 2.702 . . . . 0.0 113.335 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -49.2 -43.01 41.96 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.031 1.332 . . . . 0.0 113.077 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -47.43 -35.51 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.303 1.441 . . . . 0.0 112.966 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.2 m -51.3 -46.99 62.72 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.243 1.017 . . . . 0.0 111.19 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -90.16 -47.15 7.99 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.976 1.31 . . . . 0.0 110.422 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.454 -0.232 0 C-N-CA 124.325 1.05 . . . . 0.0 108.988 179.202 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 90.4 m . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.07 157.06 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.404 2.736 . . . . 0.0 113.838 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.58 -38.14 66.35 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.684 1.194 . . . . 0.0 111.953 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.93 -36.1 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.191 1.796 . . . . 0.0 111.811 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.95 -31.46 72.71 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.649 0.78 . . . . 0.0 112.823 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 C--N 1.34 0.193 0 C-N-CA 124.33 1.052 . . . . 0.0 111.204 -172.009 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.47 151.97 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.974 2.449 . . . . 0.0 113.36 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -53.41 -32.7 50.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.605 1.162 . . . . 0.0 112.368 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.0 t -51.94 -37.87 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.347 1.459 . . . . 0.0 111.309 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -59.6 -38.07 80.28 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.838 0.855 . . . . 0.0 112.148 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -98.56 -53.7 3.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.138 0.975 . . . . 0.0 110.809 -169.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 CA--C 1.533 0.298 0 C-N-CA 125.571 1.548 . . . . 0.0 109.952 -178.318 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.52 -45.36 87.56 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.949 0.899 . . . . 0.0 109.659 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 58.2 m -89.43 158.28 46.16 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.548 1.139 . . . . 0.0 108.075 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.21 146.42 69.76 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.193 1.929 . . . . 0.0 111.722 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.17 -41.02 59.89 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.57 1.548 . . . . 0.0 112.997 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.47 -38.01 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.515 1.526 . . . . 0.0 112.853 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.5 m -60.33 -36.59 78.3 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.325 1.05 . . . . 0.0 112.415 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -89.99 -56.86 3.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.132 0.973 . . . . 0.0 109.485 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.87 123.33 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 125.562 1.545 . . . . 0.0 108.63 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.45 -64.4 0.53 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.54 -124.13 2.5 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 170.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -138.1 -65.55 0.51 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.366 1.066 . . . . 0.0 108.35 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.03 115.58 2.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -153.06 44.15 0.64 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.424 0.69 . . . . 0.0 110.4 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 m -139.84 160.7 59.79 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 126.099 1.76 . . . . 0.0 108.667 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.46 159.27 53.2 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.934 2.423 . . . . 0.0 110.664 172.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -51.28 -41.91 60.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.989 1.315 . . . . 0.0 112.735 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.8 t -51.92 -38.77 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.343 1.457 . . . . 0.0 112.191 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.0 m -55.53 -38.71 69.6 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.545 0.738 . . . . 0.0 111.836 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -89.45 -52.63 4.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.81 0.844 . . . . 0.0 109.209 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -83.12 73.01 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.631 1.172 . . . . 0.0 107.97 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.051 0 CA-C-N 116.447 -0.342 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.665 0 CA-C-O 119.791 -0.147 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.9 tp -91.79 -54.39 3.89 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.5 m -89.86 177.07 2.61 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.936 1.294 . . . . 0.0 109.474 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -58.89 149.54 77.92 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.774 2.316 . . . . 0.0 112.166 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.0 -42.95 60.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.899 1.28 . . . . 0.0 113.136 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -53.33 -31.46 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.706 1.202 . . . . 0.0 112.907 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.6 m -55.04 -43.23 73.57 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.073 0.549 . . . . 0.0 111.072 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -89.87 -47.61 7.77 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.539 1.136 . . . . 0.0 109.735 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.27 85.68 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.606 1.162 . . . . 0.0 108.197 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.76 58.58 1.6 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.406 1.003 . . . . 0.0 110.613 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.23 111.12 0.3 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -76.78 -54.24 6.88 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.76 53.52 1.95 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.129 1.372 . . . . 0.0 108.687 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.68 -51.93 7.26 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.129 0.971 . . . . 0.0 109.031 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.8 m -89.53 176.74 2.89 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.476 1.111 . . . . 0.0 108.828 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -58.02 151.88 55.03 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.409 2.073 . . . . 0.0 112.468 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -52.49 -40.38 62.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.713 1.205 . . . . 0.0 112.98 -172.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -49.17 -35.83 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.647 1.579 . . . . 0.0 112.423 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -52.75 -47.1 67.66 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.15 0.98 . . . . 0.0 111.066 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -89.74 -49.83 6.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.062 0.945 . . . . 0.0 110.816 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 m -73.26 -32.23 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.002 0 O-C-N 121.893 -0.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -153.47 46.17 0.65 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.254 1.021 . . . . 0.0 109.926 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.6 m -136.24 156.59 76.67 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 124.987 1.315 . . . . 0.0 109.756 -176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.19 162.8 41.34 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.314 2.676 . . . . 0.0 110.684 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.28 -37.64 56.09 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.935 1.294 . . . . 0.0 112.754 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.0 t -51.33 -40.33 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.328 1.451 . . . . 0.0 111.901 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.4 m -59.51 -36.77 76.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.552 0.741 . . . . 0.0 111.955 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -89.4 -53.06 4.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.734 0.814 . . . . 0.0 109.832 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.6 t -125.14 89.76 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 125.452 1.501 . . . . 0.0 107.508 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.45 162.23 20.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.8 47.15 3.78 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 123.519 0.581 . . . . 0.0 112.689 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -162.43 70.77 0.3 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.369 1.068 . . . . 0.0 108.242 174.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.27 11.7 7.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.669 0.788 . . . . 0.0 112.119 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.7 mt -80.41 70.19 7.04 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.261 1.025 . . . . 0.0 108.668 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.3 m -131.06 162.01 58.21 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.272 1.429 . . . . 0.0 108.933 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -49.95 138.24 35.14 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.658 2.905 . . . . 0.0 113.497 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.51 -39.7 73.76 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.081 0.952 . . . . 0.0 111.813 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.21 -38.5 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.644 1.578 . . . . 0.0 111.448 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.4 m -55.31 -36.38 66.14 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.645 0.778 . . . . 0.0 112.249 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -89.48 -50.77 5.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.913 0.885 . . . . 0.0 109.408 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.57 130.33 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 124.55 1.14 . . . . 0.0 108.873 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.042 0 O-C-N 122.011 -0.431 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.66 -44.7 77.23 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.512 0.725 . . . . 0.0 110.228 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.2 m -130.66 160.51 65.94 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.645 1.578 . . . . 0.0 108.749 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.4 158.64 51.59 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.843 2.362 . . . . 0.0 111.763 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.97 -41.45 62.13 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.156 1.382 . . . . 0.0 112.581 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.5 t -48.77 -47.74 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.981 1.312 . . . . 0.0 111.317 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.6 m -63.0 -22.43 66.85 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -89.35 -58.74 2.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.5 m -85.57 62.56 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.122 0.569 . . . . 0.0 109.956 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.37 62.9 0.15 Allowed Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.642 1.115 . . . . 0.0 111.443 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -170.82 86.81 0.08 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -61.59 -50.3 73.16 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.306 0.643 . . . . 0.0 109.776 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.91 42.62 1.33 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.272 1.029 . . . . 0.0 109.934 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.08 -57.72 3.68 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 m -89.47 159.85 43.3 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.573 1.149 . . . . 0.0 108.99 172.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.77 156.84 64.1 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.166 2.578 . . . . 0.0 111.937 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.52 -21.99 66.84 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.799 1.239 . . . . 0.0 113.811 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -53.4 -36.23 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.562 0.745 . . . . 0.0 111.504 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.9 m -74.73 -26.19 59.63 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.567 0.747 . . . . 0.0 112.91 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -89.43 -54.15 4.22 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.416 0.553 . . . . 0.0 109.941 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.3 m -120.9 -34.81 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.394 1.477 . . . . 0.0 110.737 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.052 0 O-C-N 121.88 -0.512 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.22 -47.2 68.5 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.356 0.662 . . . . 0.0 110.08 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.6 m -128.5 160.92 60.04 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 125.199 1.4 . . . . 0.0 109.099 175.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.83 157.97 53.5 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.078 2.518 . . . . 0.0 112.009 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.24 -36.42 66.02 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.219 1.407 . . . . 0.0 113.392 -173.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.8 p -52.32 -39.39 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.299 1.04 . . . . 0.0 112.631 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.2 m -67.66 -27.99 67.33 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -89.78 -61.65 1.64 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.498 0.719 . . . . 0.0 109.141 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.45 78.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.146 1.378 . . . . 0.0 107.593 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.79 156.74 9.86 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.56 -30.67 75.15 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.878 0.751 . . . . 0.0 112.312 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -79.12 67.47 4.84 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.33 1.052 . . . . 0.0 110.219 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.85 53.41 1.65 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.007 1.323 . . . . 0.0 110.439 177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -93.46 66.7 3.93 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.719 1.208 . . . . 0.0 107.749 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.7 m -145.17 153.1 52.43 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 124.884 1.274 . . . . 0.0 108.449 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.35 165.61 32.17 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.468 2.779 . . . . 0.0 112.198 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -52.64 -45.53 66.72 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.673 1.189 . . . . 0.0 111.823 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.05 -40.82 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 111.576 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.8 m -63.75 -26.22 68.54 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -89.52 -51.96 5.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.576 0.75 . . . . 0.0 109.019 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.51 70.9 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.046 1.338 . . . . 0.0 108.089 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.045 0 O-C-N 122.067 -0.395 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 120.35 0.119 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.58 -47.31 41.49 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.829 0.852 . . . . 0.0 109.0 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.1 m -89.18 170.58 10.55 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.324 1.05 . . . . 0.0 108.568 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.01 153.4 20.79 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.906 2.404 . . . . 0.0 112.049 169.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.93 -37.59 45.12 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.914 1.286 . . . . 0.0 113.623 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.77 -31.17 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.199 1.0 . . . . 0.0 112.56 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.3 m -74.19 10.54 1.21 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.096 0.958 . . . . 0.0 113.053 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -137.99 -57.01 0.67 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.7 t -71.06 92.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.03 45.33 42.0 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -172.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.68 79.59 0.2 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -65.76 -61.48 2.05 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.336 0.654 . . . . 0.0 110.685 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.64 73.03 0.48 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.815 0.846 . . . . 0.0 109.377 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -151.92 43.36 0.72 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.432 0.693 . . . . 0.0 110.947 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.3 m -147.0 166.06 17.36 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 126.5 1.92 . . . . 0.0 107.18 175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.1 127.41 12.67 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.515 2.81 . . . . 0.0 113.174 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -48.35 -44.24 34.19 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.389 1.475 . . . . 0.0 112.973 -171.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 p -50.7 -34.39 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.964 1.306 . . . . 0.0 112.924 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.8 m -64.42 -29.97 71.01 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -89.8 -54.66 3.95 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.866 0.866 . . . . 0.0 109.011 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.3 72.13 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.855 1.262 . . . . 0.0 108.202 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.044 0 O-C-N 122.1 -0.375 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.82 -47.84 76.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.843 0.857 . . . . 0.0 109.582 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.0 m -89.53 157.22 47.32 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 124.509 1.124 . . . . 0.0 108.346 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.14 153.21 75.33 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.375 2.05 . . . . 0.0 111.296 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.18 -38.23 38.75 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.339 1.456 . . . . 0.0 112.728 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.8 t -51.01 -37.91 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.317 1.447 . . . . 0.0 112.086 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 83.1 m -56.07 -42.06 76.08 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.075 0.95 . . . . 0.0 111.504 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -89.52 -52.96 4.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.035 0.934 . . . . 0.0 109.823 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.9 t -135.87 107.14 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 125.141 1.376 . . . . 0.0 107.691 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.58 -69.73 0.09 OUTLIER Glycine 0 C--N 1.337 0.587 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 171.57 -53.69 0.18 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -80.95 71.99 7.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.787 0.835 . . . . 0.0 109.129 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.06 4.7 6.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.71 1.204 . . . . 0.0 112.734 175.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.64 71.21 5.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 63.2 m -126.08 158.86 64.75 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.566 1.547 . . . . 0.0 108.455 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.06 143.7 13.55 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.822 3.015 . . . . 0.0 113.524 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.0 -39.52 72.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.731 0.812 . . . . 0.0 111.776 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 p -56.74 -27.24 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.949 1.3 . . . . 0.0 112.807 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -51.78 -46.68 64.25 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.226 0.611 . . . . 0.0 110.358 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -89.78 -47.96 7.56 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.795 1.238 . . . . 0.0 109.478 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 t -81.7 72.05 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.707 1.203 . . . . 0.0 108.04 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.063 0 O-C-N 122.119 -0.363 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.718 0.294 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -64.81 -33.75 76.72 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.258 0.623 . . . . 0.0 111.685 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.1 m -89.72 168.9 13.73 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.74 1.216 . . . . 0.0 108.661 174.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -52.18 140.99 50.11 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.344 2.696 . . . . 0.0 113.857 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.0 -35.09 61.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.13 1.372 . . . . 0.0 112.952 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.84 -30.46 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.939 0.896 . . . . 0.0 112.133 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.5 m -77.17 24.06 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.508 0.723 . . . . 0.0 112.736 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -148.77 -55.56 0.2 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.48 85.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.73 56.12 3.67 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.0 85.31 0.08 OUTLIER Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.74 -45.26 75.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.726 0.811 . . . . 0.0 110.873 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.13 53.05 1.28 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.582 1.153 . . . . 0.0 108.836 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.9 tp -83.03 -41.13 19.03 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.343 1.057 . . . . 0.0 109.786 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.2 m -89.05 168.55 15.17 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.491 1.116 . . . . 0.0 109.157 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -62.57 151.5 82.94 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.424 2.083 . . . . 0.0 110.948 170.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -47.59 -40.96 20.66 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.116 1.766 . . . . 0.0 113.52 -173.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 p -46.12 -39.79 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.592 1.557 . . . . 0.0 112.791 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.7 m -60.17 -36.06 76.73 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.983 0.913 . . . . 0.0 112.14 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -89.28 -49.61 6.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.798 0.839 . . . . 0.0 110.46 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.3 m -71.77 -33.9 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 117.799 0.272 . . . . 0.0 111.613 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.001 0 O-C-N 121.923 -0.485 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.45 -56.61 5.14 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.4 m -103.67 166.32 11.93 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.203 1.801 . . . . 0.0 109.435 171.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -54.23 154.03 19.9 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.893 3.062 . . . . 0.0 113.855 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.35 -42.86 74.45 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.156 1.383 . . . . 0.0 113.039 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.48 -34.33 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.468 1.107 . . . . 0.0 112.846 -175.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.0 m -65.71 -22.73 66.64 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -89.79 -51.28 5.58 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.3 t -82.28 73.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.648 1.179 . . . . 0.0 108.759 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.27 63.86 1.83 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 123.861 0.743 . . . . 0.0 111.929 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.34 44.69 0.09 OUTLIER Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -63.98 -8.87 12.83 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.367 1.467 . . . . 0.0 114.139 -169.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.73 37.71 1.82 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.878 0.763 . . . . 0.0 110.921 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.3 mt -97.47 -46.31 6.1 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.663 0.785 . . . . 0.0 109.355 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.2 m -89.43 162.45 36.76 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.926 0.89 . . . . 0.0 110.194 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -53.45 151.96 22.12 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.977 3.118 . . . . 0.0 113.893 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -55.4 -43.58 75.35 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.85 1.26 . . . . 0.0 112.804 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -55.13 -32.81 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.704 1.202 . . . . 0.0 112.98 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.2 m -64.96 -25.86 68.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.215 0.462 . . . . 0.0 112.241 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -89.56 -52.85 4.8 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.5 t -84.41 71.64 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.78 1.232 . . . . 0.0 108.151 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.08 0 CA-C-N 116.47 -0.332 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 70.7 mt -66.55 -53.34 35.79 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.103 0.561 . . . . 0.0 110.261 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 78.9 m -101.76 176.85 1.68 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.882 1.273 . . . . 0.0 109.67 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.76 154.16 62.64 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.836 2.358 . . . . 0.0 112.313 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.19 -41.48 68.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.679 1.192 . . . . 0.0 113.176 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -51.12 -34.38 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.915 1.286 . . . . 0.0 112.545 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.9 m -56.21 -43.49 78.59 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.036 0.934 . . . . 0.0 111.175 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -93.18 -58.23 2.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.561 1.144 . . . . 0.0 110.034 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.7 t -117.37 101.04 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.595 1.558 . . . . 0.0 107.061 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.41 -29.06 0.09 OUTLIER Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.328 -175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.18 -44.7 2.47 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -77.06 68.29 3.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.533 1.133 . . . . 0.0 109.179 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.32 39.63 0.53 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.002 1.321 . . . . 0.0 111.983 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.7 mp -85.69 69.03 10.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.457 1.103 . . . . 0.0 108.186 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 m -139.93 152.18 67.2 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 125.074 1.35 . . . . 0.0 107.71 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.16 159.26 52.99 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.81 2.34 . . . . 0.0 112.31 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -52.42 -36.27 53.9 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.241 1.416 . . . . 0.0 112.239 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.1 t -46.86 -40.45 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.55 1.54 . . . . 0.0 111.596 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.8 m -55.34 -45.56 76.4 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.103 0.961 . . . . 0.0 111.709 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -89.63 -37.48 14.61 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.376 1.07 . . . . 0.0 110.945 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.0 -49.3 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.969 0.907 . . . . 0.0 109.681 174.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.05 0 O-C-N 122.066 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 111.387 0.143 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.52 -5.78 42.29 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.342 1.057 . . . . 0.0 112.704 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.0 m -89.28 164.76 29.08 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 118.927 0.785 . . . . 0.0 110.198 -173.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -58.58 152.39 55.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.423 2.748 . . . . 0.0 114.22 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.23 76.73 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.296 1.038 . . . . 0.0 111.036 173.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -51.15 -44.01 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.118 1.367 . . . . 0.0 110.769 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 54.1 m -65.69 -20.02 66.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -89.44 -21.85 22.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.452 0.569 . . . . 0.0 110.94 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.8 108.68 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.04 -41.38 10.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.681 1.61 . . . . 0.0 113.497 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.36 -34.75 26.78 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.993 1.282 . . . . 0.0 113.606 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -140.31 63.38 1.47 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.8 0.8 . . . . 0.0 108.951 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.13 58.29 2.95 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.802 0.841 . . . . 0.0 110.908 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.99 59.91 4.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.187 0.995 . . . . 0.0 110.607 -169.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.8 m -143.74 155.37 59.77 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.643 1.177 . . . . 0.0 108.277 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.73 164.44 13.67 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.966 2.444 . . . . 0.0 113.02 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -55.68 -31.36 62.33 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.039 1.336 . . . . 0.0 113.24 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.8 p -49.26 -41.44 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.095 1.358 . . . . 0.0 112.055 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.3 m -61.07 -34.33 74.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.483 1.113 . . . . 0.0 111.868 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -91.97 -48.53 6.71 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.299 1.039 . . . . 0.0 110.505 -170.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.53 -37.74 71.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.871 0.468 . . . . 0.0 110.942 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.063 0 O-C-N 121.89 -0.506 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.1 72.1 6.88 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.069 0.948 . . . . 0.0 108.921 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 63.3 m -137.26 154.57 75.7 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.453 1.501 . . . . 0.0 108.257 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.64 149.63 79.29 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.83 2.354 . . . . 0.0 111.578 -177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.76 -42.71 65.22 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.284 1.434 . . . . 0.0 112.753 -174.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -54.56 -34.38 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.462 1.105 . . . . 0.0 112.699 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.2 m -65.9 -26.42 67.61 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -89.42 -56.36 3.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -82.59 73.29 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 124.737 1.215 . . . . 0.0 108.075 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.59 -57.61 0.04 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.14 -119.03 0.46 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -119.3 -99.26 0.44 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.394 1.078 . . . . 0.0 109.232 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.98 66.69 9.31 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.763 0.825 . . . . 0.0 111.38 -172.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.81 -58.45 2.99 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.5 m -89.52 169.36 12.9 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.628 1.171 . . . . 0.0 107.841 169.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -55.97 161.25 8.78 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.293 2.662 . . . . 0.0 114.126 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.34 -39.58 70.19 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.08 1.352 . . . . 0.0 113.452 -172.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -53.47 -31.52 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.018 1.327 . . . . 0.0 112.983 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.0 m -52.66 -46.45 67.18 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.22 1.008 . . . . 0.0 111.14 177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.36 -47.4 7.49 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.906 1.283 . . . . 0.0 108.867 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.56 72.34 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.931 1.292 . . . . 0.0 107.967 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.061 0 O-C-N 122.089 -0.382 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.7 mt -68.16 -43.54 77.98 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.48 0.712 . . . . 0.0 110.163 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 m -134.09 160.6 67.89 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 125.84 1.656 . . . . 0.0 108.52 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.93 163.87 35.85 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.852 2.368 . . . . 0.0 112.133 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.52 -39.9 71.11 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.661 1.184 . . . . 0.0 111.746 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.2 t -51.87 -47.49 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.459 1.103 . . . . 0.0 110.397 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 m -66.65 -16.64 64.35 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -93.46 -12.99 28.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.701 0.801 . . . . 0.0 112.144 174.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.0 t -70.59 112.37 5.35 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 169.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.18 86.43 0.06 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.06 1.314 . . . . 0.0 110.561 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 158.11 -46.82 0.46 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -105.12 34.92 3.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.765 1.226 . . . . 0.0 109.607 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.31 70.04 8.07 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.357 1.063 . . . . 0.0 110.485 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -108.07 54.09 0.67 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.484 1.114 . . . . 0.0 110.559 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.9 m -139.53 160.64 60.72 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.172 0.989 . . . . 0.0 109.353 173.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.08 152.19 38.63 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.319 2.679 . . . . 0.0 113.707 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -59.06 -22.52 60.88 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.653 1.181 . . . . 0.0 112.596 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -52.13 -46.22 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.832 1.253 . . . . 0.0 110.703 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.7 m -66.22 -29.56 69.84 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.362 0.665 . . . . 0.0 112.496 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -89.71 -35.15 15.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.782 0.833 . . . . 0.0 111.26 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 p -152.15 -42.75 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.71 1.204 . . . . 0.0 110.485 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.01 0 O-C-N 121.8 -0.562 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 120.655 0.264 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.85 -36.85 80.18 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.408 0.683 . . . . 0.0 112.045 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.1 m -107.44 169.27 6.89 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.144 1.377 . . . . 0.0 108.847 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.56 143.39 68.21 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.519 2.812 . . . . 0.0 114.081 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.02 -39.73 82.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.692 1.197 . . . . 0.0 112.373 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.52 -32.16 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.714 1.206 . . . . 0.0 112.361 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -61.4 -34.49 75.45 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.794 0.438 . . . . 0.0 111.95 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -89.46 -49.94 6.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.437 0.695 . . . . 0.0 109.406 -177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.47 80.98 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.244 1.418 . . . . 0.0 108.95 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.98 156.54 9.79 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.236 -1.145 . . . . 0.0 110.236 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.38 53.98 4.91 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -161.41 78.22 0.56 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.57 43.57 0.67 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.505 1.122 . . . . 0.0 111.368 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.1 tp -87.71 71.83 9.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.392 1.077 . . . . 0.0 108.771 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 m -148.51 140.8 14.77 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.438 1.095 . . . . 0.0 109.327 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -51.75 162.95 1.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 124.218 3.278 . . . . 0.0 114.243 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.87 -47.8 76.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.959 1.304 . . . . 0.0 112.306 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -56.4 -28.73 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.758 1.223 . . . . 0.0 112.955 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -58.78 -35.45 72.83 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.289 0.635 . . . . 0.0 111.532 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -89.36 -58.07 2.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.916 0.887 . . . . 0.0 109.043 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.5 m -92.13 66.66 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.668 0.746 . . . . 0.0 109.084 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.05 0 CA-C-N 116.197 -0.456 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.8 tp -73.36 -57.15 4.21 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m -89.96 -177.28 0.77 Allowed Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.877 1.271 . . . . 0.0 108.394 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -55.08 136.9 75.08 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.796 2.331 . . . . 0.0 112.918 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.02 -41.67 59.96 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.327 1.451 . . . . 0.0 113.193 -173.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.5 p -51.93 -34.37 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.812 1.245 . . . . 0.0 112.77 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.6 m -59.87 -36.04 76.08 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.199 0.6 . . . . 0.0 112.003 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -89.78 -46.48 8.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.3 t -85.17 82.44 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.682 1.193 . . . . 0.0 108.854 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.14 -55.07 0.56 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.848 0.737 . . . . 0.0 112.896 169.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.18 62.24 4.28 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 117.61 0.705 . . . . 0.0 112.071 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -51.82 -24.42 6.05 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.189 1.795 . . . . 0.0 115.362 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.23 37.49 3.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.881 0.872 . . . . 0.0 110.761 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -82.64 -46.0 13.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -88.75 161.65 41.02 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.989 0.916 . . . . 0.0 109.226 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.54 167.42 24.21 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.931 2.421 . . . . 0.0 111.013 172.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -52.27 -40.83 62.25 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.995 1.318 . . . . 0.0 112.375 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -47.29 -45.14 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.959 1.703 . . . . 0.0 111.917 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.3 m -61.28 -35.25 76.79 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.068 0.947 . . . . 0.0 112.429 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -89.71 -47.83 7.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.697 0.799 . . . . 0.0 110.909 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.77 146.88 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.858 1.263 . . . . 0.0 109.607 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.09 0 O-C-N 122.114 -0.366 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.19 -62.46 1.53 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.833 0.853 . . . . 0.0 110.01 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.9 m -102.12 166.04 12.82 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.558 1.143 . . . . 0.0 109.184 171.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.92 155.04 35.04 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.351 2.7 . . . . 0.0 113.685 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.01 -33.8 67.54 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.961 1.304 . . . . 0.0 112.797 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.66 -38.35 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.293 1.437 . . . . 0.0 111.925 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 m -64.3 -31.99 73.41 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -91.78 -56.0 3.26 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.232 0.613 . . . . 0.0 110.049 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 m -127.07 64.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 125.76 1.624 . . . . 0.0 109.516 -172.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.3 -67.92 0.01 OUTLIER Glycine 0 C--N 1.337 0.594 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.18 -46.13 0.39 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -79.16 73.41 5.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.181 0.992 . . . . 0.0 109.447 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 59.33 0.8 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.899 1.679 . . . . 0.0 110.92 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.9 mt -101.99 55.04 0.8 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.584 1.554 . . . . 0.0 108.172 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.9 m -132.4 153.87 81.37 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.03 1.332 . . . . 0.0 109.099 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.03 167.95 25.9 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.319 2.679 . . . . 0.0 111.859 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -54.21 -37.85 65.01 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.844 1.258 . . . . 0.0 111.805 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.4 t -54.51 -43.47 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.035 1.334 . . . . 0.0 111.006 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.4 m -71.58 -21.12 61.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.72 -48.14 7.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.286 0.634 . . . . 0.0 110.555 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.9 m -138.57 146.03 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.923 1.289 . . . . 0.0 109.495 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.084 0 O-C-N 122.101 -0.375 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.04 -47.91 84.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.872 0.869 . . . . 0.0 110.145 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.0 m -140.26 164.56 36.38 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.979 1.311 . . . . 0.0 108.277 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.68 144.02 44.5 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.253 2.636 . . . . 0.0 112.798 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.49 -40.93 65.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.385 1.074 . . . . 0.0 112.478 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -52.93 -31.71 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.091 1.357 . . . . 0.0 112.72 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.4 m -58.0 -44.75 87.38 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.359 1.064 . . . . 0.0 111.034 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -89.66 -53.56 4.46 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.953 0.901 . . . . 0.0 110.28 -174.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.74 103.23 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 124.991 1.317 . . . . 0.0 107.683 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.27 -71.74 0.1 OUTLIER Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 176.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.55 -49.13 0.23 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -77.63 72.64 4.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.369 1.068 . . . . 0.0 109.616 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.34 4.94 5.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.733 1.213 . . . . 0.0 112.615 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.5 mt -76.96 71.4 3.46 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.455 1.102 . . . . 0.0 109.024 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.7 m -130.77 160.34 66.96 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.718 1.607 . . . . 0.0 108.4 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -49.84 145.18 18.96 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.543 2.829 . . . . 0.0 113.744 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.59 -38.71 67.05 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.049 0.94 . . . . 0.0 111.412 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.9 t -51.33 -35.35 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.832 1.653 . . . . 0.0 112.076 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.9 m -50.96 -48.2 61.05 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.814 0.846 . . . . 0.0 110.785 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -89.58 -48.6 7.19 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.299 1.04 . . . . 0.0 109.593 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -82.0 72.24 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.747 1.219 . . . . 0.0 107.891 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.078 0 O-C-N 122.048 -0.407 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -62.92 -39.35 94.3 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.565 0.746 . . . . 0.0 111.852 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.8 m -89.98 157.95 45.15 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.714 1.205 . . . . 0.0 107.869 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -65.87 141.62 65.85 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.258 1.972 . . . . 0.0 111.743 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.56 53.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.672 1.589 . . . . 0.0 113.211 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.96 -31.92 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.719 1.207 . . . . 0.0 112.598 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.6 m -64.2 -36.77 85.15 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.085 0.554 . . . . 0.0 111.959 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -89.8 -56.46 3.23 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.805 0.842 . . . . 0.0 109.765 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.2 m -124.3 73.59 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 125.736 1.614 . . . . 0.0 109.232 -173.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.58 -70.67 0.03 OUTLIER Glycine 0 C--N 1.337 0.605 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.59 -37.58 0.67 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -77.59 74.26 4.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.362 1.065 . . . . 0.0 109.154 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.31 42.54 0.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.269 1.828 . . . . 0.0 112.352 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.2 tp -86.3 69.44 10.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.3 m -145.83 143.8 20.58 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.08 163.86 37.77 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.383 2.722 . . . . 0.0 111.665 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.29 -44.57 54.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.78 1.632 . . . . 0.0 112.768 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.07 -31.4 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.807 1.243 . . . . 0.0 112.917 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.1 m -57.65 -42.72 84.02 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.152 0.581 . . . . 0.0 111.197 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -89.47 -48.77 7.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.956 0.902 . . . . 0.0 110.485 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.4 t -71.26 -46.1 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.526 0.73 . . . . 0.0 110.461 -178.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.074 0 O-C-N 121.932 -0.48 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.383 0.135 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.5 mp -64.23 -46.74 82.5 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.956 0.902 . . . . 0.0 109.689 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.9 m -89.73 164.2 29.89 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.631 1.572 . . . . 0.0 107.621 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.72 140.65 56.87 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.155 1.903 . . . . 0.0 112.018 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.65 -26.62 14.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.666 1.987 . . . . 0.0 114.483 -172.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.7 p -52.42 -32.21 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.81 0.844 . . . . 0.0 111.953 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.49 12.01 15.56 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -124.22 -44.8 2.0 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 126.084 1.754 . . . . 0.0 109.186 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.3 m -123.86 142.81 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.566 1.546 . . . . 0.0 108.095 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.63 -75.57 2.22 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -170.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.85 75.47 2.35 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 107.138 -2.385 . . . . 0.0 107.138 169.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -35.42 -59.74 0.52 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.515 1.926 . . . . 0.0 114.251 -169.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.73 115.39 2.74 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -163.18 33.05 0.09 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.709 0.804 . . . . 0.0 112.018 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 92.4 m -130.45 163.19 49.85 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.687 1.195 . . . . 0.0 108.964 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -52.72 147.47 31.36 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.353 2.702 . . . . 0.0 113.335 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -49.2 -43.01 41.96 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.031 1.332 . . . . 0.0 113.077 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -47.43 -35.51 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.303 1.441 . . . . 0.0 112.966 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.2 m -51.3 -46.99 62.72 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.243 1.017 . . . . 0.0 111.19 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -90.16 -47.15 7.99 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.976 1.31 . . . . 0.0 110.422 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.5 p -154.63 132.26 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.325 1.05 . . . . 0.0 108.988 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.078 0 O-C-N 122.038 -0.414 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.1 -60.99 2.79 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.065 0.946 . . . . 0.0 109.99 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 90.4 m -106.9 165.76 12.3 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 125.43 1.492 . . . . 0.0 109.14 173.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.07 157.06 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.404 2.736 . . . . 0.0 113.838 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.58 -38.14 66.35 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.684 1.194 . . . . 0.0 111.953 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.93 -36.1 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.191 1.796 . . . . 0.0 111.811 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.95 -31.46 72.71 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.649 0.78 . . . . 0.0 112.823 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -101.39 -45.71 5.23 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.33 1.052 . . . . 0.0 111.204 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.17 139.33 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 125.679 1.592 . . . . 0.0 107.649 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.68 54.46 10.0 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.4 127.64 5.63 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 107.007 -2.437 . . . . 0.0 107.007 -168.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -112.39 -37.84 4.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.364 1.066 . . . . 0.0 111.308 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.34 91.96 3.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.665 1.186 . . . . 0.0 108.582 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -153.9 -28.75 0.13 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.707 0.803 . . . . 0.0 112.598 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 76.1 m -89.25 168.3 15.65 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.617 0.767 . . . . 0.0 109.028 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.47 151.97 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.974 2.449 . . . . 0.0 113.36 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -53.41 -32.7 50.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.605 1.162 . . . . 0.0 112.368 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.0 t -51.94 -37.87 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.347 1.459 . . . . 0.0 111.309 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -59.6 -38.07 80.28 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.838 0.855 . . . . 0.0 112.148 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -98.56 -53.7 3.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.138 0.975 . . . . 0.0 110.809 -169.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 m -129.7 42.56 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.571 1.548 . . . . 0.0 109.952 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.072 0 O-C-N 121.664 -0.648 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 58.2 m . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.21 146.42 69.76 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.193 1.929 . . . . 0.0 111.722 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.17 -41.02 59.89 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.57 1.548 . . . . 0.0 112.997 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.47 -38.01 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.515 1.526 . . . . 0.0 112.853 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.5 m -60.33 -36.59 78.3 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.325 1.05 . . . . 0.0 112.415 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 N--CA 1.453 -0.303 0 C-N-CA 124.132 0.973 . . . . 0.0 109.485 -177.875 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.46 159.27 53.2 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.934 2.423 . . . . 0.0 110.664 172.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -51.28 -41.91 60.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.989 1.315 . . . . 0.0 112.735 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.8 t -51.92 -38.77 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.343 1.457 . . . . 0.0 112.191 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.0 m -55.53 -38.71 69.6 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.545 0.738 . . . . 0.0 111.836 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -89.45 -52.63 4.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.81 0.844 . . . . 0.0 109.209 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 124.631 1.172 . . . . 0.0 107.97 176.897 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.5 m . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -58.89 149.54 77.92 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.774 2.316 . . . . 0.0 112.166 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.0 -42.95 60.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.899 1.28 . . . . 0.0 113.136 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -53.33 -31.46 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.706 1.202 . . . . 0.0 112.907 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.6 m -55.04 -43.23 73.57 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.073 0.549 . . . . 0.0 111.072 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 . . . . . 0 N--CA 1.454 -0.228 0 C-N-CA 124.539 1.136 . . . . 0.0 109.735 -175.212 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -58.02 151.88 55.03 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.409 2.073 . . . . 0.0 112.468 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -52.49 -40.38 62.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.713 1.205 . . . . 0.0 112.98 -172.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -49.17 -35.83 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.647 1.579 . . . . 0.0 112.423 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -52.75 -47.1 67.66 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.15 0.98 . . . . 0.0 111.066 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -89.74 -49.83 6.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.062 0.945 . . . . 0.0 110.816 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 m . . . . . 0 CA--C 1.533 0.308 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -176.043 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.19 162.8 41.34 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.314 2.676 . . . . 0.0 110.684 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.28 -37.64 56.09 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.935 1.294 . . . . 0.0 112.754 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.0 t -51.33 -40.33 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.328 1.451 . . . . 0.0 111.901 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.4 m -59.51 -36.77 76.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.552 0.741 . . . . 0.0 111.955 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 . . . . . 0 N--CA 1.454 -0.234 0 C-N-CA 123.734 0.814 . . . . 0.0 109.832 -176.187 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.3 m . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -49.95 138.24 35.14 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.658 2.905 . . . . 0.0 113.497 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.51 -39.7 73.76 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.081 0.952 . . . . 0.0 111.813 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.21 -38.5 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.644 1.578 . . . . 0.0 111.448 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.4 m -55.31 -36.38 66.14 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.645 0.778 . . . . 0.0 112.249 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -89.48 -50.77 5.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.913 0.885 . . . . 0.0 109.408 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.454 -0.247 0 C-N-CA 124.55 1.14 . . . . 0.0 108.873 177.285 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.48 ' N ' ' HH ' ' A' ' 8' ' ' TYR . 20.2 m . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.4 158.64 51.59 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.843 2.362 . . . . 0.0 111.763 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.97 -41.45 62.13 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.156 1.382 . . . . 0.0 112.581 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.5 t -48.77 -47.74 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.981 1.312 . . . . 0.0 111.317 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.6 m -63.0 -22.43 66.85 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.48 ' HH ' ' N ' ' A' ' 3' ' ' CYS . 16.5 m-85 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 m . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.77 156.84 64.1 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.166 2.578 . . . . 0.0 111.937 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.52 -21.99 66.84 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.799 1.239 . . . . 0.0 113.811 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -53.4 -36.23 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.562 0.745 . . . . 0.0 111.504 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.9 m -74.73 -26.19 59.63 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.567 0.747 . . . . 0.0 112.91 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -89.43 -54.15 4.22 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.416 0.553 . . . . 0.0 109.941 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 125.394 1.477 . . . . 0.0 110.737 -178.263 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.83 157.97 53.5 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.078 2.518 . . . . 0.0 112.009 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.24 -36.42 66.02 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.219 1.407 . . . . 0.0 113.392 -173.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.8 p -52.32 -39.39 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.299 1.04 . . . . 0.0 112.631 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.2 m -67.66 -27.99 67.33 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 N--CA 1.454 -0.25 0 C-N-CA 123.498 0.719 . . . . 0.0 109.141 -179.047 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.7 m . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.35 165.61 32.17 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.468 2.779 . . . . 0.0 112.198 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -52.64 -45.53 66.72 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.673 1.189 . . . . 0.0 111.823 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.05 -40.82 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 111.576 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.8 m -63.75 -26.22 68.54 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -89.52 -51.96 5.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.576 0.75 . . . . 0.0 109.019 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 CA--C 1.533 0.314 0 C-N-CA 125.046 1.338 . . . . 0.0 108.089 178.017 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.01 153.4 20.79 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.906 2.404 . . . . 0.0 112.049 169.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.93 -37.59 45.12 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.914 1.286 . . . . 0.0 113.623 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.77 -31.17 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.199 1.0 . . . . 0.0 112.56 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.3 m -74.19 10.54 1.21 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.096 0.958 . . . . 0.0 113.053 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.341 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.3 m . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.1 127.41 12.67 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.515 2.81 . . . . 0.0 113.174 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -48.35 -44.24 34.19 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.389 1.475 . . . . 0.0 112.973 -171.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 p -50.7 -34.39 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.964 1.306 . . . . 0.0 112.924 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.8 m -64.42 -29.97 71.01 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -89.8 -54.66 3.95 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.866 0.866 . . . . 0.0 109.011 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.532 0.28 0 C-N-CA 124.855 1.262 . . . . 0.0 108.202 178.556 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.0 m . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.14 153.21 75.33 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.375 2.05 . . . . 0.0 111.296 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.18 -38.23 38.75 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.339 1.456 . . . . 0.0 112.728 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.8 t -51.01 -37.91 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.317 1.447 . . . . 0.0 112.086 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 83.1 m -56.07 -42.06 76.08 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.075 0.95 . . . . 0.0 111.504 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 N--CA 1.454 -0.268 0 C-N-CA 124.035 0.934 . . . . 0.0 109.823 -173.735 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 63.2 m . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.06 143.7 13.55 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.822 3.015 . . . . 0.0 113.524 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.0 -39.52 72.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.731 0.812 . . . . 0.0 111.776 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 p -56.74 -27.24 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.949 1.3 . . . . 0.0 112.807 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -51.78 -46.68 64.25 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.226 0.611 . . . . 0.0 110.358 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -89.78 -47.96 7.56 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.795 1.238 . . . . 0.0 109.478 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.534 0.336 0 C-N-CA 124.707 1.203 . . . . 0.0 108.04 176.867 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.1 m . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -52.18 140.99 50.11 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.344 2.696 . . . . 0.0 113.857 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.0 -35.09 61.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.13 1.372 . . . . 0.0 112.952 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.84 -30.46 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.939 0.896 . . . . 0.0 112.133 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.5 m -77.17 24.06 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.508 0.723 . . . . 0.0 112.736 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.343 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -62.57 151.5 82.94 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.424 2.083 . . . . 0.0 110.948 170.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -47.59 -40.96 20.66 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.116 1.766 . . . . 0.0 113.52 -173.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 p -46.12 -39.79 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.592 1.557 . . . . 0.0 112.791 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.7 m -60.17 -36.06 76.73 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.983 0.913 . . . . 0.0 112.14 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -89.28 -49.61 6.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.798 0.839 . . . . 0.0 110.46 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.3 m . . . . . 0 CA--C 1.533 0.326 0 CA-C-N 117.799 0.272 . . . . 0.0 111.613 -178.432 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.4 m . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -54.23 154.03 19.9 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.893 3.062 . . . . 0.0 113.855 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.35 -42.86 74.45 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.156 1.383 . . . . 0.0 113.039 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.48 -34.33 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.468 1.107 . . . . 0.0 112.846 -175.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.0 m -65.71 -22.73 66.64 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.249 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 119.32 -0.371 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -53.45 151.96 22.12 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.977 3.118 . . . . 0.0 113.893 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -55.4 -43.58 75.35 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.85 1.26 . . . . 0.0 112.804 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -55.13 -32.81 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.704 1.202 . . . . 0.0 112.98 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.2 m -64.96 -25.86 68.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.215 0.462 . . . . 0.0 112.241 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -89.56 -52.85 4.8 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 CA--C 1.533 0.3 0 C-N-CA 124.78 1.232 . . . . 0.0 108.151 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 78.9 m . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.76 154.16 62.64 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.836 2.358 . . . . 0.0 112.313 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.19 -41.48 68.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.679 1.192 . . . . 0.0 113.176 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -51.12 -34.38 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.915 1.286 . . . . 0.0 112.545 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.9 m -56.21 -43.49 78.59 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.036 0.934 . . . . 0.0 111.175 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 124.561 1.144 . . . . 0.0 110.034 -173.678 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.16 159.26 52.99 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.81 2.34 . . . . 0.0 112.31 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -52.42 -36.27 53.9 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.241 1.416 . . . . 0.0 112.239 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.1 t -46.86 -40.45 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.55 1.54 . . . . 0.0 111.596 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.8 m -55.34 -45.56 76.4 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.103 0.961 . . . . 0.0 111.709 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -89.63 -37.48 14.61 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.376 1.07 . . . . 0.0 110.945 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.8 t . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 123.969 0.907 . . . . 0.0 109.681 174.928 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.0 m . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -58.58 152.39 55.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.423 2.748 . . . . 0.0 114.22 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.23 76.73 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.296 1.038 . . . . 0.0 111.036 173.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -51.15 -44.01 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.118 1.367 . . . . 0.0 110.769 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 54.1 m -65.69 -20.02 66.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 . . . . . 0 CA--C 1.531 0.217 0 CA-C-N 118.452 0.569 . . . . 0.0 110.94 176.216 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.8 m . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.73 164.44 13.67 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.966 2.444 . . . . 0.0 113.02 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -55.68 -31.36 62.33 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.039 1.336 . . . . 0.0 113.24 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.8 p -49.26 -41.44 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.095 1.358 . . . . 0.0 112.055 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.3 m -61.07 -34.33 74.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.483 1.113 . . . . 0.0 111.868 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -91.97 -48.53 6.71 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.299 1.039 . . . . 0.0 110.505 -170.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.533 0.325 0 C-N-CA 122.871 0.468 . . . . 0.0 110.942 179.422 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 63.3 m . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.64 149.63 79.29 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.83 2.354 . . . . 0.0 111.578 -177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.76 -42.71 65.22 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.284 1.434 . . . . 0.0 112.753 -174.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -54.56 -34.38 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.462 1.105 . . . . 0.0 112.699 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.2 m -65.9 -26.42 67.61 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 174.485 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -55.97 161.25 8.78 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.293 2.662 . . . . 0.0 114.126 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.34 -39.58 70.19 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.08 1.352 . . . . 0.0 113.452 -172.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -53.47 -31.52 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.018 1.327 . . . . 0.0 112.983 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.0 m -52.66 -46.45 67.18 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.22 1.008 . . . . 0.0 111.14 177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.36 -47.4 7.49 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.906 1.283 . . . . 0.0 108.867 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 124.931 1.292 . . . . 0.0 107.967 176.548 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.539 ' N ' ' HH ' ' A' ' 8' ' ' TYR . 16.5 m . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.93 163.87 35.85 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.852 2.368 . . . . 0.0 112.133 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.52 -39.9 71.11 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.661 1.184 . . . . 0.0 111.746 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.2 t -51.87 -47.49 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.459 1.103 . . . . 0.0 110.397 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 m -66.65 -16.64 64.35 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.539 ' HH ' ' N ' ' A' ' 3' ' ' CYS . 16.3 m-85 . . . . . 0 CA--C 1.533 0.304 0 C-N-CA 123.701 0.801 . . . . 0.0 112.144 174.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.9 m . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.08 152.19 38.63 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.319 2.679 . . . . 0.0 113.707 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -59.06 -22.52 60.88 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.653 1.181 . . . . 0.0 112.596 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -52.13 -46.22 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.832 1.253 . . . . 0.0 110.703 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.7 m -66.22 -29.56 69.84 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.362 0.665 . . . . 0.0 112.496 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -89.71 -35.15 15.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.782 0.833 . . . . 0.0 111.26 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 124.71 1.204 . . . . 0.0 110.485 -177.876 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.1 m . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.56 143.39 68.21 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.519 2.812 . . . . 0.0 114.081 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.02 -39.73 82.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.692 1.197 . . . . 0.0 112.373 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.52 -32.16 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.714 1.206 . . . . 0.0 112.361 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -61.4 -34.49 75.45 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.794 0.438 . . . . 0.0 111.95 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 N--CA 1.455 -0.19 0 C-N-CA 123.437 0.695 . . . . 0.0 109.406 -177.559 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 m . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -51.75 162.95 1.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 124.218 3.278 . . . . 0.0 114.243 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.87 -47.8 76.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.959 1.304 . . . . 0.0 112.306 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -56.4 -28.73 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.758 1.223 . . . . 0.0 112.955 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -58.78 -35.45 72.83 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.289 0.635 . . . . 0.0 111.532 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -89.36 -58.07 2.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.916 0.887 . . . . 0.0 109.043 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.5 m . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 121.668 0.746 . . . . 0.0 109.084 176.149 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -55.08 136.9 75.08 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.796 2.331 . . . . 0.0 112.918 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.02 -41.67 59.96 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.327 1.451 . . . . 0.0 113.193 -173.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.5 p -51.93 -34.37 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.812 1.245 . . . . 0.0 112.77 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.6 m -59.87 -36.04 76.08 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.199 0.6 . . . . 0.0 112.003 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.523 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.54 167.42 24.21 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.931 2.421 . . . . 0.0 111.013 172.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -52.27 -40.83 62.25 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.995 1.318 . . . . 0.0 112.375 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -47.29 -45.14 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.959 1.703 . . . . 0.0 111.917 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.3 m -61.28 -35.25 76.79 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.068 0.947 . . . . 0.0 112.429 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -89.71 -47.83 7.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.697 0.799 . . . . 0.0 110.909 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 CA--C 1.53 0.192 0 C-N-CA 124.858 1.263 . . . . 0.0 109.607 -177.574 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.9 m . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.92 155.04 35.04 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.351 2.7 . . . . 0.0 113.685 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.01 -33.8 67.54 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.961 1.304 . . . . 0.0 112.797 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.66 -38.35 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.293 1.437 . . . . 0.0 111.925 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 m -64.3 -31.99 73.41 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 CA--C 1.531 0.223 0 C-N-CA 123.232 0.613 . . . . 0.0 110.049 -176.69 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.9 m . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.03 167.95 25.9 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.319 2.679 . . . . 0.0 111.859 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -54.21 -37.85 65.01 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.844 1.258 . . . . 0.0 111.805 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.4 t -54.51 -43.47 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.035 1.334 . . . . 0.0 111.006 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.4 m -71.58 -21.12 61.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.72 -48.14 7.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.286 0.634 . . . . 0.0 110.555 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.9 m . . . . . 0 CA--C 1.53 0.205 0 C-N-CA 124.923 1.289 . . . . 0.0 109.495 -178.821 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.0 m . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.68 144.02 44.5 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.253 2.636 . . . . 0.0 112.798 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.49 -40.93 65.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.385 1.074 . . . . 0.0 112.478 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -52.93 -31.71 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.091 1.357 . . . . 0.0 112.72 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.4 m -58.0 -44.75 87.38 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.359 1.064 . . . . 0.0 111.034 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 123.953 0.901 . . . . 0.0 110.28 -174.21 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.7 m . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -49.84 145.18 18.96 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.543 2.829 . . . . 0.0 113.744 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.59 -38.71 67.05 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.049 0.94 . . . . 0.0 111.412 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.9 t -51.33 -35.35 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.832 1.653 . . . . 0.0 112.076 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.9 m -50.96 -48.2 61.05 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.814 0.846 . . . . 0.0 110.785 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -89.58 -48.6 7.19 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.299 1.04 . . . . 0.0 109.593 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 124.747 1.219 . . . . 0.0 107.891 175.625 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.8 m . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -65.87 141.62 65.85 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.258 1.972 . . . . 0.0 111.743 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.56 53.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.672 1.589 . . . . 0.0 113.211 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.96 -31.92 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.719 1.207 . . . . 0.0 112.598 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.6 m -64.2 -36.77 85.15 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.085 0.554 . . . . 0.0 111.959 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 123.805 0.842 . . . . 0.0 109.765 -177.255 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.08 163.86 37.77 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.383 2.722 . . . . 0.0 111.665 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.29 -44.57 54.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.78 1.632 . . . . 0.0 112.768 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.07 -31.4 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.807 1.243 . . . . 0.0 112.917 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.1 m -57.65 -42.72 84.02 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.152 0.581 . . . . 0.0 111.197 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -89.47 -48.77 7.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.956 0.902 . . . . 0.0 110.485 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.4 t . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 123.526 0.73 . . . . 0.0 110.461 -178.01 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.9 m . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.72 140.65 56.87 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.155 1.903 . . . . 0.0 112.018 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.65 -26.62 14.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.666 1.987 . . . . 0.0 114.483 -172.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.7 p -52.42 -32.21 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.81 0.844 . . . . 0.0 111.953 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.49 12.01 15.56 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 . . . . . 0 C--N 1.342 0.279 0 C-N-CA 126.084 1.754 . . . . 0.0 109.186 -177.818 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 92.4 m . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -52.72 147.47 31.36 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.353 2.702 . . . . 0.0 113.335 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -49.2 -43.01 41.96 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.031 1.332 . . . . 0.0 113.077 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -47.43 -35.51 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.303 1.441 . . . . 0.0 112.966 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.2 m -51.3 -46.99 62.72 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.243 1.017 . . . . 0.0 111.19 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -90.16 -47.15 7.99 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.976 1.31 . . . . 0.0 110.422 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.454 -0.232 0 C-N-CA 124.325 1.05 . . . . 0.0 108.988 179.202 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 90.4 m . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.07 157.06 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.404 2.736 . . . . 0.0 113.838 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.58 -38.14 66.35 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.684 1.194 . . . . 0.0 111.953 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.93 -36.1 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.191 1.796 . . . . 0.0 111.811 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.95 -31.46 72.71 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.649 0.78 . . . . 0.0 112.823 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 C--N 1.34 0.193 0 C-N-CA 124.33 1.052 . . . . 0.0 111.204 -172.009 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.475 ' N ' ' HH ' ' A' ' 20' ' ' TYR . 76.1 m . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.47 151.97 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.974 2.449 . . . . 0.0 113.36 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -53.41 -32.7 50.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.605 1.162 . . . . 0.0 112.368 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.0 t -51.94 -37.87 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.347 1.459 . . . . 0.0 111.309 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -59.6 -38.07 80.28 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.838 0.855 . . . . 0.0 112.148 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.475 ' HH ' ' N ' ' A' ' 15' ' ' CYS . 14.1 m-85 -98.56 -53.7 3.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.138 0.975 . . . . 0.0 110.809 -169.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 CA--C 1.533 0.298 0 C-N-CA 125.571 1.548 . . . . 0.0 109.952 -178.318 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.52 -45.36 87.56 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.949 0.899 . . . . 0.0 109.659 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 58.2 m -89.43 158.28 46.16 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.548 1.139 . . . . 0.0 108.075 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.21 146.42 69.76 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.193 1.929 . . . . 0.0 111.722 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.17 -41.02 59.89 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.57 1.548 . . . . 0.0 112.997 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.47 -38.01 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.515 1.526 . . . . 0.0 112.853 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.5 m -60.33 -36.59 78.3 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.325 1.05 . . . . 0.0 112.415 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -89.99 -56.86 3.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.132 0.973 . . . . 0.0 109.485 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.87 123.33 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 125.562 1.545 . . . . 0.0 108.63 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.45 -64.4 0.53 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.54 -124.13 2.5 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 170.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -138.1 -65.55 0.51 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.366 1.066 . . . . 0.0 108.35 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.03 115.58 2.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -153.06 44.15 0.64 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.424 0.69 . . . . 0.0 110.4 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 m -139.84 160.7 59.79 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 126.099 1.76 . . . . 0.0 108.667 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.46 159.27 53.2 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.934 2.423 . . . . 0.0 110.664 172.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -51.28 -41.91 60.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.989 1.315 . . . . 0.0 112.735 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.8 t -51.92 -38.77 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.343 1.457 . . . . 0.0 112.191 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.0 m -55.53 -38.71 69.6 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.545 0.738 . . . . 0.0 111.836 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -89.45 -52.63 4.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.81 0.844 . . . . 0.0 109.209 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -83.12 73.01 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.631 1.172 . . . . 0.0 107.97 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.051 0 CA-C-N 116.447 -0.342 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.665 0 CA-C-O 119.791 -0.147 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.9 tp -91.79 -54.39 3.89 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.5 m -89.86 177.07 2.61 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.936 1.294 . . . . 0.0 109.474 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -58.89 149.54 77.92 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.774 2.316 . . . . 0.0 112.166 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.0 -42.95 60.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.899 1.28 . . . . 0.0 113.136 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -53.33 -31.46 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.706 1.202 . . . . 0.0 112.907 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.6 m -55.04 -43.23 73.57 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.073 0.549 . . . . 0.0 111.072 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -89.87 -47.61 7.77 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.539 1.136 . . . . 0.0 109.735 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.27 85.68 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.606 1.162 . . . . 0.0 108.197 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.76 58.58 1.6 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.406 1.003 . . . . 0.0 110.613 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.23 111.12 0.3 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -76.78 -54.24 6.88 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.76 53.52 1.95 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.129 1.372 . . . . 0.0 108.687 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.68 -51.93 7.26 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.129 0.971 . . . . 0.0 109.031 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.8 m -89.53 176.74 2.89 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.476 1.111 . . . . 0.0 108.828 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -58.02 151.88 55.03 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.409 2.073 . . . . 0.0 112.468 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -52.49 -40.38 62.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.713 1.205 . . . . 0.0 112.98 -172.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -49.17 -35.83 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.647 1.579 . . . . 0.0 112.423 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -52.75 -47.1 67.66 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.15 0.98 . . . . 0.0 111.066 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -89.74 -49.83 6.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.062 0.945 . . . . 0.0 110.816 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 m -73.26 -32.23 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.002 0 O-C-N 121.893 -0.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -153.47 46.17 0.65 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.254 1.021 . . . . 0.0 109.926 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.6 m -136.24 156.59 76.67 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 124.987 1.315 . . . . 0.0 109.756 -176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.19 162.8 41.34 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.314 2.676 . . . . 0.0 110.684 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.28 -37.64 56.09 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.935 1.294 . . . . 0.0 112.754 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.0 t -51.33 -40.33 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.328 1.451 . . . . 0.0 111.901 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.4 m -59.51 -36.77 76.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.552 0.741 . . . . 0.0 111.955 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -89.4 -53.06 4.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.734 0.814 . . . . 0.0 109.832 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.6 t -125.14 89.76 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 125.452 1.501 . . . . 0.0 107.508 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.45 162.23 20.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.8 47.15 3.78 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 123.519 0.581 . . . . 0.0 112.689 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -162.43 70.77 0.3 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.369 1.068 . . . . 0.0 108.242 174.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.27 11.7 7.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.669 0.788 . . . . 0.0 112.119 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.7 mt -80.41 70.19 7.04 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.261 1.025 . . . . 0.0 108.668 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.3 m -131.06 162.01 58.21 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.272 1.429 . . . . 0.0 108.933 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -49.95 138.24 35.14 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.658 2.905 . . . . 0.0 113.497 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.51 -39.7 73.76 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.081 0.952 . . . . 0.0 111.813 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.21 -38.5 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.644 1.578 . . . . 0.0 111.448 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.4 m -55.31 -36.38 66.14 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.645 0.778 . . . . 0.0 112.249 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -89.48 -50.77 5.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.913 0.885 . . . . 0.0 109.408 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.57 130.33 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 124.55 1.14 . . . . 0.0 108.873 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.042 0 O-C-N 122.011 -0.431 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.66 -44.7 77.23 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.512 0.725 . . . . 0.0 110.228 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.2 m -130.66 160.51 65.94 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.645 1.578 . . . . 0.0 108.749 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.4 158.64 51.59 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.843 2.362 . . . . 0.0 111.763 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.97 -41.45 62.13 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.156 1.382 . . . . 0.0 112.581 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.5 t -48.77 -47.74 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.981 1.312 . . . . 0.0 111.317 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.6 m -63.0 -22.43 66.85 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -89.35 -58.74 2.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.5 m -85.57 62.56 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.122 0.569 . . . . 0.0 109.956 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.37 62.9 0.15 Allowed Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.642 1.115 . . . . 0.0 111.443 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -170.82 86.81 0.08 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -61.59 -50.3 73.16 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.306 0.643 . . . . 0.0 109.776 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.91 42.62 1.33 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.272 1.029 . . . . 0.0 109.934 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.08 -57.72 3.68 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 m -89.47 159.85 43.3 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.573 1.149 . . . . 0.0 108.99 172.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.77 156.84 64.1 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.166 2.578 . . . . 0.0 111.937 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.52 -21.99 66.84 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.799 1.239 . . . . 0.0 113.811 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -53.4 -36.23 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.562 0.745 . . . . 0.0 111.504 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.9 m -74.73 -26.19 59.63 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.567 0.747 . . . . 0.0 112.91 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -89.43 -54.15 4.22 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.416 0.553 . . . . 0.0 109.941 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.3 m -120.9 -34.81 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.394 1.477 . . . . 0.0 110.737 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.052 0 O-C-N 121.88 -0.512 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.22 -47.2 68.5 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.356 0.662 . . . . 0.0 110.08 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.6 m -128.5 160.92 60.04 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 125.199 1.4 . . . . 0.0 109.099 175.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.83 157.97 53.5 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.078 2.518 . . . . 0.0 112.009 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.24 -36.42 66.02 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.219 1.407 . . . . 0.0 113.392 -173.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.8 p -52.32 -39.39 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.299 1.04 . . . . 0.0 112.631 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.2 m -67.66 -27.99 67.33 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -89.78 -61.65 1.64 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.498 0.719 . . . . 0.0 109.141 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.45 78.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.146 1.378 . . . . 0.0 107.593 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.79 156.74 9.86 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.56 -30.67 75.15 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.878 0.751 . . . . 0.0 112.312 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -79.12 67.47 4.84 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.33 1.052 . . . . 0.0 110.219 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.85 53.41 1.65 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.007 1.323 . . . . 0.0 110.439 177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -93.46 66.7 3.93 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.719 1.208 . . . . 0.0 107.749 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.7 m -145.17 153.1 52.43 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 124.884 1.274 . . . . 0.0 108.449 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.35 165.61 32.17 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.468 2.779 . . . . 0.0 112.198 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -52.64 -45.53 66.72 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.673 1.189 . . . . 0.0 111.823 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.05 -40.82 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 111.576 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.8 m -63.75 -26.22 68.54 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -89.52 -51.96 5.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.576 0.75 . . . . 0.0 109.019 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.51 70.9 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.046 1.338 . . . . 0.0 108.089 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.045 0 O-C-N 122.067 -0.395 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 120.35 0.119 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.58 -47.31 41.49 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.829 0.852 . . . . 0.0 109.0 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.1 m -89.18 170.58 10.55 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.324 1.05 . . . . 0.0 108.568 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.01 153.4 20.79 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.906 2.404 . . . . 0.0 112.049 169.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.93 -37.59 45.12 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.914 1.286 . . . . 0.0 113.623 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.77 -31.17 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.199 1.0 . . . . 0.0 112.56 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.3 m -74.19 10.54 1.21 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.096 0.958 . . . . 0.0 113.053 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -137.99 -57.01 0.67 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.7 t -71.06 92.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.03 45.33 42.0 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -172.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.68 79.59 0.2 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -65.76 -61.48 2.05 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.336 0.654 . . . . 0.0 110.685 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.64 73.03 0.48 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.815 0.846 . . . . 0.0 109.377 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -151.92 43.36 0.72 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.432 0.693 . . . . 0.0 110.947 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.3 m -147.0 166.06 17.36 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 126.5 1.92 . . . . 0.0 107.18 175.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.1 127.41 12.67 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.515 2.81 . . . . 0.0 113.174 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -48.35 -44.24 34.19 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.389 1.475 . . . . 0.0 112.973 -171.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 p -50.7 -34.39 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.964 1.306 . . . . 0.0 112.924 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.8 m -64.42 -29.97 71.01 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -89.8 -54.66 3.95 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.866 0.866 . . . . 0.0 109.011 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.3 72.13 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.855 1.262 . . . . 0.0 108.202 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.044 0 O-C-N 122.1 -0.375 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.82 -47.84 76.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.843 0.857 . . . . 0.0 109.582 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.0 m -89.53 157.22 47.32 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 124.509 1.124 . . . . 0.0 108.346 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.14 153.21 75.33 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.375 2.05 . . . . 0.0 111.296 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.18 -38.23 38.75 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.339 1.456 . . . . 0.0 112.728 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.8 t -51.01 -37.91 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.317 1.447 . . . . 0.0 112.086 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 83.1 m -56.07 -42.06 76.08 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.075 0.95 . . . . 0.0 111.504 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -89.52 -52.96 4.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.035 0.934 . . . . 0.0 109.823 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.9 t -135.87 107.14 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 125.141 1.376 . . . . 0.0 107.691 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.58 -69.73 0.09 OUTLIER Glycine 0 C--N 1.337 0.587 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 171.57 -53.69 0.18 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -80.95 71.99 7.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.787 0.835 . . . . 0.0 109.129 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.06 4.7 6.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.71 1.204 . . . . 0.0 112.734 175.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.64 71.21 5.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 63.2 m -126.08 158.86 64.75 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.566 1.547 . . . . 0.0 108.455 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.06 143.7 13.55 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.822 3.015 . . . . 0.0 113.524 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.0 -39.52 72.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.731 0.812 . . . . 0.0 111.776 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 p -56.74 -27.24 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.949 1.3 . . . . 0.0 112.807 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -51.78 -46.68 64.25 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.226 0.611 . . . . 0.0 110.358 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -89.78 -47.96 7.56 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.795 1.238 . . . . 0.0 109.478 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 t -81.7 72.05 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.707 1.203 . . . . 0.0 108.04 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.063 0 O-C-N 122.119 -0.363 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.718 0.294 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -64.81 -33.75 76.72 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.258 0.623 . . . . 0.0 111.685 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.1 m -89.72 168.9 13.73 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.74 1.216 . . . . 0.0 108.661 174.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -52.18 140.99 50.11 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.344 2.696 . . . . 0.0 113.857 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.0 -35.09 61.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.13 1.372 . . . . 0.0 112.952 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.84 -30.46 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.939 0.896 . . . . 0.0 112.133 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.5 m -77.17 24.06 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.508 0.723 . . . . 0.0 112.736 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -148.77 -55.56 0.2 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.48 85.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.73 56.12 3.67 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.0 85.31 0.08 OUTLIER Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.74 -45.26 75.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.726 0.811 . . . . 0.0 110.873 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.13 53.05 1.28 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.582 1.153 . . . . 0.0 108.836 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.9 tp -83.03 -41.13 19.03 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.343 1.057 . . . . 0.0 109.786 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.2 m -89.05 168.55 15.17 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.491 1.116 . . . . 0.0 109.157 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -62.57 151.5 82.94 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.424 2.083 . . . . 0.0 110.948 170.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -47.59 -40.96 20.66 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.116 1.766 . . . . 0.0 113.52 -173.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 p -46.12 -39.79 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.592 1.557 . . . . 0.0 112.791 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.7 m -60.17 -36.06 76.73 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.983 0.913 . . . . 0.0 112.14 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -89.28 -49.61 6.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.798 0.839 . . . . 0.0 110.46 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.3 m -71.77 -33.9 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 117.799 0.272 . . . . 0.0 111.613 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.001 0 O-C-N 121.923 -0.485 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.45 -56.61 5.14 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.4 m -103.67 166.32 11.93 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.203 1.801 . . . . 0.0 109.435 171.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -54.23 154.03 19.9 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.893 3.062 . . . . 0.0 113.855 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.35 -42.86 74.45 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.156 1.383 . . . . 0.0 113.039 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.48 -34.33 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.468 1.107 . . . . 0.0 112.846 -175.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.0 m -65.71 -22.73 66.64 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -89.79 -51.28 5.58 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.3 t -82.28 73.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.648 1.179 . . . . 0.0 108.759 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.27 63.86 1.83 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 123.861 0.743 . . . . 0.0 111.929 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.34 44.69 0.09 OUTLIER Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -63.98 -8.87 12.83 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.367 1.467 . . . . 0.0 114.139 -169.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.73 37.71 1.82 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.878 0.763 . . . . 0.0 110.921 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.3 mt -97.47 -46.31 6.1 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.663 0.785 . . . . 0.0 109.355 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.2 m -89.43 162.45 36.76 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.926 0.89 . . . . 0.0 110.194 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -53.45 151.96 22.12 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.977 3.118 . . . . 0.0 113.893 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -55.4 -43.58 75.35 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.85 1.26 . . . . 0.0 112.804 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -55.13 -32.81 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.704 1.202 . . . . 0.0 112.98 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.2 m -64.96 -25.86 68.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.215 0.462 . . . . 0.0 112.241 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -89.56 -52.85 4.8 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.5 t -84.41 71.64 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.78 1.232 . . . . 0.0 108.151 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.08 0 CA-C-N 116.47 -0.332 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 70.7 mt -66.55 -53.34 35.79 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.103 0.561 . . . . 0.0 110.261 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 78.9 m -101.76 176.85 1.68 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.882 1.273 . . . . 0.0 109.67 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.76 154.16 62.64 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.836 2.358 . . . . 0.0 112.313 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.19 -41.48 68.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.679 1.192 . . . . 0.0 113.176 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -51.12 -34.38 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.915 1.286 . . . . 0.0 112.545 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.9 m -56.21 -43.49 78.59 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.036 0.934 . . . . 0.0 111.175 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -93.18 -58.23 2.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.561 1.144 . . . . 0.0 110.034 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.7 t -117.37 101.04 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.595 1.558 . . . . 0.0 107.061 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.41 -29.06 0.09 OUTLIER Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.328 -175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.18 -44.7 2.47 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -77.06 68.29 3.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.533 1.133 . . . . 0.0 109.179 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.32 39.63 0.53 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.002 1.321 . . . . 0.0 111.983 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.7 mp -85.69 69.03 10.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.457 1.103 . . . . 0.0 108.186 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 m -139.93 152.18 67.2 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 125.074 1.35 . . . . 0.0 107.71 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.16 159.26 52.99 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.81 2.34 . . . . 0.0 112.31 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -52.42 -36.27 53.9 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.241 1.416 . . . . 0.0 112.239 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.1 t -46.86 -40.45 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.55 1.54 . . . . 0.0 111.596 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.8 m -55.34 -45.56 76.4 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.103 0.961 . . . . 0.0 111.709 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -89.63 -37.48 14.61 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.376 1.07 . . . . 0.0 110.945 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.0 -49.3 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.969 0.907 . . . . 0.0 109.681 174.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.05 0 O-C-N 122.066 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 111.387 0.143 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.52 -5.78 42.29 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.342 1.057 . . . . 0.0 112.704 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.0 m -89.28 164.76 29.08 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 118.927 0.785 . . . . 0.0 110.198 -173.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -58.58 152.39 55.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.423 2.748 . . . . 0.0 114.22 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.23 76.73 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.296 1.038 . . . . 0.0 111.036 173.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -51.15 -44.01 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.118 1.367 . . . . 0.0 110.769 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 54.1 m -65.69 -20.02 66.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -89.44 -21.85 22.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.452 0.569 . . . . 0.0 110.94 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.8 108.68 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.04 -41.38 10.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.681 1.61 . . . . 0.0 113.497 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.36 -34.75 26.78 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.993 1.282 . . . . 0.0 113.606 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -140.31 63.38 1.47 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.8 0.8 . . . . 0.0 108.951 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.13 58.29 2.95 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.802 0.841 . . . . 0.0 110.908 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.99 59.91 4.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.187 0.995 . . . . 0.0 110.607 -169.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.8 m -143.74 155.37 59.77 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.643 1.177 . . . . 0.0 108.277 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.73 164.44 13.67 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.966 2.444 . . . . 0.0 113.02 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -55.68 -31.36 62.33 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.039 1.336 . . . . 0.0 113.24 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.8 p -49.26 -41.44 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.095 1.358 . . . . 0.0 112.055 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.3 m -61.07 -34.33 74.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.483 1.113 . . . . 0.0 111.868 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -91.97 -48.53 6.71 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.299 1.039 . . . . 0.0 110.505 -170.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.53 -37.74 71.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.871 0.468 . . . . 0.0 110.942 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.063 0 O-C-N 121.89 -0.506 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.1 72.1 6.88 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.069 0.948 . . . . 0.0 108.921 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 63.3 m -137.26 154.57 75.7 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.453 1.501 . . . . 0.0 108.257 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.64 149.63 79.29 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.83 2.354 . . . . 0.0 111.578 -177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.76 -42.71 65.22 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.284 1.434 . . . . 0.0 112.753 -174.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -54.56 -34.38 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.462 1.105 . . . . 0.0 112.699 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.2 m -65.9 -26.42 67.61 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -89.42 -56.36 3.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -82.59 73.29 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 124.737 1.215 . . . . 0.0 108.075 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.59 -57.61 0.04 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.14 -119.03 0.46 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -119.3 -99.26 0.44 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.394 1.078 . . . . 0.0 109.232 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.98 66.69 9.31 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.763 0.825 . . . . 0.0 111.38 -172.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.81 -58.45 2.99 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.5 m -89.52 169.36 12.9 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.628 1.171 . . . . 0.0 107.841 169.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -55.97 161.25 8.78 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.293 2.662 . . . . 0.0 114.126 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.34 -39.58 70.19 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.08 1.352 . . . . 0.0 113.452 -172.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -53.47 -31.52 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.018 1.327 . . . . 0.0 112.983 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.0 m -52.66 -46.45 67.18 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.22 1.008 . . . . 0.0 111.14 177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.36 -47.4 7.49 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.906 1.283 . . . . 0.0 108.867 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.56 72.34 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.931 1.292 . . . . 0.0 107.967 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.061 0 O-C-N 122.089 -0.382 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.7 mt -68.16 -43.54 77.98 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.48 0.712 . . . . 0.0 110.163 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 m -134.09 160.6 67.89 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 125.84 1.656 . . . . 0.0 108.52 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.93 163.87 35.85 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.852 2.368 . . . . 0.0 112.133 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.52 -39.9 71.11 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.661 1.184 . . . . 0.0 111.746 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.2 t -51.87 -47.49 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.459 1.103 . . . . 0.0 110.397 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 m -66.65 -16.64 64.35 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -93.46 -12.99 28.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.701 0.801 . . . . 0.0 112.144 174.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.0 t -70.59 112.37 5.35 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 169.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.18 86.43 0.06 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.06 1.314 . . . . 0.0 110.561 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 158.11 -46.82 0.46 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -105.12 34.92 3.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.765 1.226 . . . . 0.0 109.607 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.31 70.04 8.07 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.357 1.063 . . . . 0.0 110.485 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -108.07 54.09 0.67 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.484 1.114 . . . . 0.0 110.559 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.9 m -139.53 160.64 60.72 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.172 0.989 . . . . 0.0 109.353 173.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.08 152.19 38.63 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.319 2.679 . . . . 0.0 113.707 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -59.06 -22.52 60.88 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.653 1.181 . . . . 0.0 112.596 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -52.13 -46.22 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.832 1.253 . . . . 0.0 110.703 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.7 m -66.22 -29.56 69.84 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.362 0.665 . . . . 0.0 112.496 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -89.71 -35.15 15.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.782 0.833 . . . . 0.0 111.26 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 p -152.15 -42.75 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.71 1.204 . . . . 0.0 110.485 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.01 0 O-C-N 121.8 -0.562 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 120.655 0.264 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.85 -36.85 80.18 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.408 0.683 . . . . 0.0 112.045 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.1 m -107.44 169.27 6.89 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.144 1.377 . . . . 0.0 108.847 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.56 143.39 68.21 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.519 2.812 . . . . 0.0 114.081 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.02 -39.73 82.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.692 1.197 . . . . 0.0 112.373 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.52 -32.16 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.714 1.206 . . . . 0.0 112.361 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -61.4 -34.49 75.45 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.794 0.438 . . . . 0.0 111.95 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -89.46 -49.94 6.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.437 0.695 . . . . 0.0 109.406 -177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.47 80.98 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.244 1.418 . . . . 0.0 108.95 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.98 156.54 9.79 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.236 -1.145 . . . . 0.0 110.236 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.38 53.98 4.91 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -161.41 78.22 0.56 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.57 43.57 0.67 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.505 1.122 . . . . 0.0 111.368 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.1 tp -87.71 71.83 9.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.392 1.077 . . . . 0.0 108.771 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 m -148.51 140.8 14.77 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.438 1.095 . . . . 0.0 109.327 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -51.75 162.95 1.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 124.218 3.278 . . . . 0.0 114.243 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.87 -47.8 76.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.959 1.304 . . . . 0.0 112.306 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -56.4 -28.73 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.758 1.223 . . . . 0.0 112.955 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -58.78 -35.45 72.83 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.289 0.635 . . . . 0.0 111.532 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -89.36 -58.07 2.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.916 0.887 . . . . 0.0 109.043 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.5 m -92.13 66.66 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.668 0.746 . . . . 0.0 109.084 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.05 0 CA-C-N 116.197 -0.456 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.8 tp -73.36 -57.15 4.21 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m -89.96 -177.28 0.77 Allowed Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.877 1.271 . . . . 0.0 108.394 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -55.08 136.9 75.08 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.796 2.331 . . . . 0.0 112.918 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.02 -41.67 59.96 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.327 1.451 . . . . 0.0 113.193 -173.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.5 p -51.93 -34.37 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.812 1.245 . . . . 0.0 112.77 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.6 m -59.87 -36.04 76.08 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.199 0.6 . . . . 0.0 112.003 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -89.78 -46.48 8.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.3 t -85.17 82.44 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.682 1.193 . . . . 0.0 108.854 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.14 -55.07 0.56 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.848 0.737 . . . . 0.0 112.896 169.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.18 62.24 4.28 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 117.61 0.705 . . . . 0.0 112.071 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -51.82 -24.42 6.05 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.189 1.795 . . . . 0.0 115.362 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.23 37.49 3.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.881 0.872 . . . . 0.0 110.761 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -82.64 -46.0 13.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -88.75 161.65 41.02 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.989 0.916 . . . . 0.0 109.226 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.54 167.42 24.21 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.931 2.421 . . . . 0.0 111.013 172.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -52.27 -40.83 62.25 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.995 1.318 . . . . 0.0 112.375 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -47.29 -45.14 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.959 1.703 . . . . 0.0 111.917 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.3 m -61.28 -35.25 76.79 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.068 0.947 . . . . 0.0 112.429 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -89.71 -47.83 7.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.697 0.799 . . . . 0.0 110.909 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.77 146.88 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.858 1.263 . . . . 0.0 109.607 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.09 0 O-C-N 122.114 -0.366 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.19 -62.46 1.53 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.833 0.853 . . . . 0.0 110.01 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.9 m -102.12 166.04 12.82 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.558 1.143 . . . . 0.0 109.184 171.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.92 155.04 35.04 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.351 2.7 . . . . 0.0 113.685 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.01 -33.8 67.54 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.961 1.304 . . . . 0.0 112.797 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.66 -38.35 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.293 1.437 . . . . 0.0 111.925 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 m -64.3 -31.99 73.41 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -91.78 -56.0 3.26 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.232 0.613 . . . . 0.0 110.049 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 m -127.07 64.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 125.76 1.624 . . . . 0.0 109.516 -172.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.3 -67.92 0.01 OUTLIER Glycine 0 C--N 1.337 0.594 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.18 -46.13 0.39 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -79.16 73.41 5.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.181 0.992 . . . . 0.0 109.447 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 59.33 0.8 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.899 1.679 . . . . 0.0 110.92 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.9 mt -101.99 55.04 0.8 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.584 1.554 . . . . 0.0 108.172 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.9 m -132.4 153.87 81.37 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.03 1.332 . . . . 0.0 109.099 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.03 167.95 25.9 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.319 2.679 . . . . 0.0 111.859 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -54.21 -37.85 65.01 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.844 1.258 . . . . 0.0 111.805 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.4 t -54.51 -43.47 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.035 1.334 . . . . 0.0 111.006 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.4 m -71.58 -21.12 61.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.72 -48.14 7.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.286 0.634 . . . . 0.0 110.555 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.9 m -138.57 146.03 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.923 1.289 . . . . 0.0 109.495 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.084 0 O-C-N 122.101 -0.375 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.04 -47.91 84.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.872 0.869 . . . . 0.0 110.145 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.0 m -140.26 164.56 36.38 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.979 1.311 . . . . 0.0 108.277 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.68 144.02 44.5 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.253 2.636 . . . . 0.0 112.798 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.49 -40.93 65.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.385 1.074 . . . . 0.0 112.478 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -52.93 -31.71 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.091 1.357 . . . . 0.0 112.72 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.4 m -58.0 -44.75 87.38 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.359 1.064 . . . . 0.0 111.034 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -89.66 -53.56 4.46 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.953 0.901 . . . . 0.0 110.28 -174.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.74 103.23 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 124.991 1.317 . . . . 0.0 107.683 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.27 -71.74 0.1 OUTLIER Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 176.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.55 -49.13 0.23 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -77.63 72.64 4.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.369 1.068 . . . . 0.0 109.616 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.34 4.94 5.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.733 1.213 . . . . 0.0 112.615 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.5 mt -76.96 71.4 3.46 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.455 1.102 . . . . 0.0 109.024 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.7 m -130.77 160.34 66.96 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.718 1.607 . . . . 0.0 108.4 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -49.84 145.18 18.96 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.543 2.829 . . . . 0.0 113.744 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.59 -38.71 67.05 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.049 0.94 . . . . 0.0 111.412 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.9 t -51.33 -35.35 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.832 1.653 . . . . 0.0 112.076 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.9 m -50.96 -48.2 61.05 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.814 0.846 . . . . 0.0 110.785 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -89.58 -48.6 7.19 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.299 1.04 . . . . 0.0 109.593 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -82.0 72.24 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.747 1.219 . . . . 0.0 107.891 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.078 0 O-C-N 122.048 -0.407 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -62.92 -39.35 94.3 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.565 0.746 . . . . 0.0 111.852 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.8 m -89.98 157.95 45.15 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.714 1.205 . . . . 0.0 107.869 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -65.87 141.62 65.85 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.258 1.972 . . . . 0.0 111.743 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.56 53.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.672 1.589 . . . . 0.0 113.211 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.96 -31.92 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.719 1.207 . . . . 0.0 112.598 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.6 m -64.2 -36.77 85.15 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.085 0.554 . . . . 0.0 111.959 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -89.8 -56.46 3.23 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.805 0.842 . . . . 0.0 109.765 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.2 m -124.3 73.59 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 125.736 1.614 . . . . 0.0 109.232 -173.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.58 -70.67 0.03 OUTLIER Glycine 0 C--N 1.337 0.605 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.59 -37.58 0.67 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -77.59 74.26 4.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.362 1.065 . . . . 0.0 109.154 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.31 42.54 0.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.269 1.828 . . . . 0.0 112.352 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.2 tp -86.3 69.44 10.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.3 m -145.83 143.8 20.58 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.08 163.86 37.77 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.383 2.722 . . . . 0.0 111.665 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.29 -44.57 54.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.78 1.632 . . . . 0.0 112.768 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.07 -31.4 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.807 1.243 . . . . 0.0 112.917 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.1 m -57.65 -42.72 84.02 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.152 0.581 . . . . 0.0 111.197 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -89.47 -48.77 7.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.956 0.902 . . . . 0.0 110.485 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.4 t -71.26 -46.1 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.526 0.73 . . . . 0.0 110.461 -178.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.074 0 O-C-N 121.932 -0.48 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.383 0.135 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.5 mp -64.23 -46.74 82.5 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.956 0.902 . . . . 0.0 109.689 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.9 m -89.73 164.2 29.89 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.631 1.572 . . . . 0.0 107.621 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.72 140.65 56.87 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.155 1.903 . . . . 0.0 112.018 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.65 -26.62 14.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.666 1.987 . . . . 0.0 114.483 -172.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.7 p -52.42 -32.21 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.81 0.844 . . . . 0.0 111.953 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.49 12.01 15.56 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -124.22 -44.8 2.0 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 126.084 1.754 . . . . 0.0 109.186 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.3 m -123.86 142.81 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.566 1.546 . . . . 0.0 108.095 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.63 -75.57 2.22 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -170.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.85 75.47 2.35 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 107.138 -2.385 . . . . 0.0 107.138 169.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -35.42 -59.74 0.52 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.515 1.926 . . . . 0.0 114.251 -169.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.73 115.39 2.74 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -163.18 33.05 0.09 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.709 0.804 . . . . 0.0 112.018 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 92.4 m -130.45 163.19 49.85 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.687 1.195 . . . . 0.0 108.964 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -52.72 147.47 31.36 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.353 2.702 . . . . 0.0 113.335 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -49.2 -43.01 41.96 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.031 1.332 . . . . 0.0 113.077 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -47.43 -35.51 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.303 1.441 . . . . 0.0 112.966 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.2 m -51.3 -46.99 62.72 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.243 1.017 . . . . 0.0 111.19 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -90.16 -47.15 7.99 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.976 1.31 . . . . 0.0 110.422 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.5 p -154.63 132.26 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.325 1.05 . . . . 0.0 108.988 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.078 0 O-C-N 122.038 -0.414 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.1 -60.99 2.79 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.065 0.946 . . . . 0.0 109.99 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 90.4 m -106.9 165.76 12.3 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 125.43 1.492 . . . . 0.0 109.14 173.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.07 157.06 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.404 2.736 . . . . 0.0 113.838 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.58 -38.14 66.35 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.684 1.194 . . . . 0.0 111.953 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.93 -36.1 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.191 1.796 . . . . 0.0 111.811 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.95 -31.46 72.71 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.649 0.78 . . . . 0.0 112.823 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -101.39 -45.71 5.23 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.33 1.052 . . . . 0.0 111.204 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.17 139.33 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 125.679 1.592 . . . . 0.0 107.649 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.68 54.46 10.0 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.4 127.64 5.63 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 107.007 -2.437 . . . . 0.0 107.007 -168.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -112.39 -37.84 4.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.364 1.066 . . . . 0.0 111.308 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.34 91.96 3.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.665 1.186 . . . . 0.0 108.582 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -153.9 -28.75 0.13 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.707 0.803 . . . . 0.0 112.598 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 76.1 m -89.25 168.3 15.65 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.617 0.767 . . . . 0.0 109.028 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.47 151.97 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.974 2.449 . . . . 0.0 113.36 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -53.41 -32.7 50.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.605 1.162 . . . . 0.0 112.368 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.0 t -51.94 -37.87 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.347 1.459 . . . . 0.0 111.309 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -59.6 -38.07 80.28 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.838 0.855 . . . . 0.0 112.148 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -98.56 -53.7 3.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.138 0.975 . . . . 0.0 110.809 -169.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 m -129.7 42.56 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.571 1.548 . . . . 0.0 109.952 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.072 0 O-C-N 121.664 -0.648 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 58.2 m . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.21 146.42 69.76 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.193 1.929 . . . . 0.0 111.722 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.17 -41.02 59.89 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.57 1.548 . . . . 0.0 112.997 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.47 -38.01 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.515 1.526 . . . . 0.0 112.853 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.5 m -60.33 -36.59 78.3 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.325 1.05 . . . . 0.0 112.415 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 . . . . . 0 N--CA 1.453 -0.303 0 C-N-CA 124.132 0.973 . . . . 0.0 109.485 -177.875 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.46 159.27 53.2 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.934 2.423 . . . . 0.0 110.664 172.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -51.28 -41.91 60.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.989 1.315 . . . . 0.0 112.735 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.8 t -51.92 -38.77 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.343 1.457 . . . . 0.0 112.191 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.0 m -55.53 -38.71 69.6 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.545 0.738 . . . . 0.0 111.836 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -89.45 -52.63 4.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.81 0.844 . . . . 0.0 109.209 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 124.631 1.172 . . . . 0.0 107.97 176.897 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.5 m . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -58.89 149.54 77.92 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.774 2.316 . . . . 0.0 112.166 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.0 -42.95 60.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.899 1.28 . . . . 0.0 113.136 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -53.33 -31.46 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.706 1.202 . . . . 0.0 112.907 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.6 m -55.04 -43.23 73.57 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.073 0.549 . . . . 0.0 111.072 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 . . . . . 0 N--CA 1.454 -0.228 0 C-N-CA 124.539 1.136 . . . . 0.0 109.735 -175.212 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -58.02 151.88 55.03 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.409 2.073 . . . . 0.0 112.468 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -52.49 -40.38 62.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.713 1.205 . . . . 0.0 112.98 -172.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -49.17 -35.83 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.647 1.579 . . . . 0.0 112.423 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -52.75 -47.1 67.66 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.15 0.98 . . . . 0.0 111.066 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -89.74 -49.83 6.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.062 0.945 . . . . 0.0 110.816 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 m . . . . . 0 CA--C 1.533 0.308 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -176.043 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.6 m . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.19 162.8 41.34 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.314 2.676 . . . . 0.0 110.684 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.28 -37.64 56.09 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.935 1.294 . . . . 0.0 112.754 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.0 t -51.33 -40.33 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.328 1.451 . . . . 0.0 111.901 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.4 m -59.51 -36.77 76.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.552 0.741 . . . . 0.0 111.955 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 . . . . . 0 N--CA 1.454 -0.234 0 C-N-CA 123.734 0.814 . . . . 0.0 109.832 -176.187 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.3 m . . . . . 0 CA--C 1.534 0.361 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -49.95 138.24 35.14 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.658 2.905 . . . . 0.0 113.497 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.51 -39.7 73.76 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.081 0.952 . . . . 0.0 111.813 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.21 -38.5 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.644 1.578 . . . . 0.0 111.448 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.4 m -55.31 -36.38 66.14 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.645 0.778 . . . . 0.0 112.249 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -89.48 -50.77 5.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.913 0.885 . . . . 0.0 109.408 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.454 -0.247 0 C-N-CA 124.55 1.14 . . . . 0.0 108.873 177.285 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.48 ' N ' ' HH ' ' A' ' 8' ' ' TYR . 20.2 m . . . . . 0 CA--C 1.532 0.269 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.4 158.64 51.59 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.843 2.362 . . . . 0.0 111.763 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.97 -41.45 62.13 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.156 1.382 . . . . 0.0 112.581 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.5 t -48.77 -47.74 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.981 1.312 . . . . 0.0 111.317 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.6 m -63.0 -22.43 66.85 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.48 ' HH ' ' N ' ' A' ' 3' ' ' CYS . 16.5 m-85 . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 m . . . . . 0 CA--C 1.535 0.39 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.77 156.84 64.1 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.166 2.578 . . . . 0.0 111.937 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.52 -21.99 66.84 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.799 1.239 . . . . 0.0 113.811 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -53.4 -36.23 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.562 0.745 . . . . 0.0 111.504 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.9 m -74.73 -26.19 59.63 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.567 0.747 . . . . 0.0 112.91 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -89.43 -54.15 4.22 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.416 0.553 . . . . 0.0 109.941 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 125.394 1.477 . . . . 0.0 110.737 -178.263 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.6 m . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.83 157.97 53.5 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.078 2.518 . . . . 0.0 112.009 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.24 -36.42 66.02 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.219 1.407 . . . . 0.0 113.392 -173.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.8 p -52.32 -39.39 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.299 1.04 . . . . 0.0 112.631 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.2 m -67.66 -27.99 67.33 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 N--CA 1.454 -0.25 0 C-N-CA 123.498 0.719 . . . . 0.0 109.141 -179.047 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.7 m . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.35 165.61 32.17 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.468 2.779 . . . . 0.0 112.198 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -52.64 -45.53 66.72 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.673 1.189 . . . . 0.0 111.823 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.05 -40.82 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 111.576 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.8 m -63.75 -26.22 68.54 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -89.52 -51.96 5.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.576 0.75 . . . . 0.0 109.019 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 CA--C 1.533 0.314 0 C-N-CA 125.046 1.338 . . . . 0.0 108.089 178.017 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.01 153.4 20.79 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.906 2.404 . . . . 0.0 112.049 169.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.93 -37.59 45.12 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.914 1.286 . . . . 0.0 113.623 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.77 -31.17 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.199 1.0 . . . . 0.0 112.56 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.3 m -74.19 10.54 1.21 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.096 0.958 . . . . 0.0 113.053 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.341 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.3 m . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.1 127.41 12.67 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.515 2.81 . . . . 0.0 113.174 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -48.35 -44.24 34.19 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.389 1.475 . . . . 0.0 112.973 -171.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 p -50.7 -34.39 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.964 1.306 . . . . 0.0 112.924 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.8 m -64.42 -29.97 71.01 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -89.8 -54.66 3.95 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.866 0.866 . . . . 0.0 109.011 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.532 0.28 0 C-N-CA 124.855 1.262 . . . . 0.0 108.202 178.556 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.0 m . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.14 153.21 75.33 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.375 2.05 . . . . 0.0 111.296 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.18 -38.23 38.75 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.339 1.456 . . . . 0.0 112.728 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.8 t -51.01 -37.91 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.317 1.447 . . . . 0.0 112.086 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 83.1 m -56.07 -42.06 76.08 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.075 0.95 . . . . 0.0 111.504 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 N--CA 1.454 -0.268 0 C-N-CA 124.035 0.934 . . . . 0.0 109.823 -173.735 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 63.2 m . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.06 143.7 13.55 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.822 3.015 . . . . 0.0 113.524 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.0 -39.52 72.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.731 0.812 . . . . 0.0 111.776 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 p -56.74 -27.24 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.949 1.3 . . . . 0.0 112.807 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -51.78 -46.68 64.25 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.226 0.611 . . . . 0.0 110.358 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -89.78 -47.96 7.56 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.795 1.238 . . . . 0.0 109.478 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 CA--C 1.534 0.336 0 C-N-CA 124.707 1.203 . . . . 0.0 108.04 176.867 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.1 m . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -52.18 140.99 50.11 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.344 2.696 . . . . 0.0 113.857 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.0 -35.09 61.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.13 1.372 . . . . 0.0 112.952 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.84 -30.46 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.939 0.896 . . . . 0.0 112.133 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.5 m -77.17 24.06 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.508 0.723 . . . . 0.0 112.736 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.343 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -62.57 151.5 82.94 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.424 2.083 . . . . 0.0 110.948 170.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -47.59 -40.96 20.66 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.116 1.766 . . . . 0.0 113.52 -173.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 p -46.12 -39.79 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.592 1.557 . . . . 0.0 112.791 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.7 m -60.17 -36.06 76.73 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.983 0.913 . . . . 0.0 112.14 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -89.28 -49.61 6.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.798 0.839 . . . . 0.0 110.46 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.3 m . . . . . 0 CA--C 1.533 0.326 0 CA-C-N 117.799 0.272 . . . . 0.0 111.613 -178.432 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.4 m . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -54.23 154.03 19.9 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.893 3.062 . . . . 0.0 113.855 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.35 -42.86 74.45 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.156 1.383 . . . . 0.0 113.039 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.48 -34.33 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.468 1.107 . . . . 0.0 112.846 -175.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.0 m -65.71 -22.73 66.64 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 CA--C 1.53 0.183 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.249 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.2 m . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 119.32 -0.371 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -53.45 151.96 22.12 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.977 3.118 . . . . 0.0 113.893 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -55.4 -43.58 75.35 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.85 1.26 . . . . 0.0 112.804 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -55.13 -32.81 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.704 1.202 . . . . 0.0 112.98 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.2 m -64.96 -25.86 68.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.215 0.462 . . . . 0.0 112.241 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -89.56 -52.85 4.8 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 CA--C 1.533 0.3 0 C-N-CA 124.78 1.232 . . . . 0.0 108.151 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 78.9 m . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.76 154.16 62.64 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.836 2.358 . . . . 0.0 112.313 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.19 -41.48 68.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.679 1.192 . . . . 0.0 113.176 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -51.12 -34.38 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.915 1.286 . . . . 0.0 112.545 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.9 m -56.21 -43.49 78.59 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.036 0.934 . . . . 0.0 111.175 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 . . . . . 0 N--CA 1.455 -0.189 0 C-N-CA 124.561 1.144 . . . . 0.0 110.034 -173.678 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 m . . . . . 0 CA--C 1.533 0.29 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.16 159.26 52.99 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.81 2.34 . . . . 0.0 112.31 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -52.42 -36.27 53.9 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.241 1.416 . . . . 0.0 112.239 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.1 t -46.86 -40.45 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.55 1.54 . . . . 0.0 111.596 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.8 m -55.34 -45.56 76.4 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.103 0.961 . . . . 0.0 111.709 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -89.63 -37.48 14.61 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.376 1.07 . . . . 0.0 110.945 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.8 t . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 123.969 0.907 . . . . 0.0 109.681 174.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.0 m . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -58.58 152.39 55.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.423 2.748 . . . . 0.0 114.22 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.23 76.73 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.296 1.038 . . . . 0.0 111.036 173.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -51.15 -44.01 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.118 1.367 . . . . 0.0 110.769 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 54.1 m -65.69 -20.02 66.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 . . . . . 0 CA--C 1.531 0.217 0 CA-C-N 118.452 0.569 . . . . 0.0 110.94 176.216 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.8 m . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.73 164.44 13.67 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.966 2.444 . . . . 0.0 113.02 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -55.68 -31.36 62.33 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.039 1.336 . . . . 0.0 113.24 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.8 p -49.26 -41.44 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.095 1.358 . . . . 0.0 112.055 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.3 m -61.07 -34.33 74.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.483 1.113 . . . . 0.0 111.868 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -91.97 -48.53 6.71 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.299 1.039 . . . . 0.0 110.505 -170.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.533 0.325 0 C-N-CA 122.871 0.468 . . . . 0.0 110.942 179.422 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 63.3 m . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.64 149.63 79.29 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.83 2.354 . . . . 0.0 111.578 -177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.76 -42.71 65.22 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.284 1.434 . . . . 0.0 112.753 -174.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -54.56 -34.38 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.462 1.105 . . . . 0.0 112.699 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.2 m -65.9 -26.42 67.61 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 174.485 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.5 m . . . . . 0 CA--C 1.54 0.568 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -55.97 161.25 8.78 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.293 2.662 . . . . 0.0 114.126 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.34 -39.58 70.19 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.08 1.352 . . . . 0.0 113.452 -172.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -53.47 -31.52 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.018 1.327 . . . . 0.0 112.983 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.0 m -52.66 -46.45 67.18 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.22 1.008 . . . . 0.0 111.14 177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.36 -47.4 7.49 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.906 1.283 . . . . 0.0 108.867 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t . . . . . 0 CA--C 1.533 0.306 0 C-N-CA 124.931 1.292 . . . . 0.0 107.967 176.548 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.539 ' N ' ' HH ' ' A' ' 8' ' ' TYR . 16.5 m . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.93 163.87 35.85 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.852 2.368 . . . . 0.0 112.133 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.52 -39.9 71.11 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.661 1.184 . . . . 0.0 111.746 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.2 t -51.87 -47.49 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.459 1.103 . . . . 0.0 110.397 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 m -66.65 -16.64 64.35 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.539 ' HH ' ' N ' ' A' ' 3' ' ' CYS . 16.3 m-85 . . . . . 0 CA--C 1.533 0.304 0 C-N-CA 123.701 0.801 . . . . 0.0 112.144 174.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.9 m . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.08 152.19 38.63 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.319 2.679 . . . . 0.0 113.707 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -59.06 -22.52 60.88 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.653 1.181 . . . . 0.0 112.596 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -52.13 -46.22 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.832 1.253 . . . . 0.0 110.703 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.7 m -66.22 -29.56 69.84 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.362 0.665 . . . . 0.0 112.496 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -89.71 -35.15 15.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.782 0.833 . . . . 0.0 111.26 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 124.71 1.204 . . . . 0.0 110.485 -177.876 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.1 m . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.56 143.39 68.21 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.519 2.812 . . . . 0.0 114.081 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.02 -39.73 82.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.692 1.197 . . . . 0.0 112.373 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.52 -32.16 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.714 1.206 . . . . 0.0 112.361 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -61.4 -34.49 75.45 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.794 0.438 . . . . 0.0 111.95 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 N--CA 1.455 -0.19 0 C-N-CA 123.437 0.695 . . . . 0.0 109.406 -177.559 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 m . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -51.75 162.95 1.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 124.218 3.278 . . . . 0.0 114.243 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.87 -47.8 76.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.959 1.304 . . . . 0.0 112.306 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -56.4 -28.73 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.758 1.223 . . . . 0.0 112.955 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -58.78 -35.45 72.83 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.289 0.635 . . . . 0.0 111.532 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -89.36 -58.07 2.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.916 0.887 . . . . 0.0 109.043 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.5 m . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 121.668 0.746 . . . . 0.0 109.084 176.149 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -55.08 136.9 75.08 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.796 2.331 . . . . 0.0 112.918 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.02 -41.67 59.96 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.327 1.451 . . . . 0.0 113.193 -173.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.5 p -51.93 -34.37 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.812 1.245 . . . . 0.0 112.77 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.6 m -59.87 -36.04 76.08 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.199 0.6 . . . . 0.0 112.003 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.523 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.54 167.42 24.21 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.931 2.421 . . . . 0.0 111.013 172.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -52.27 -40.83 62.25 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.995 1.318 . . . . 0.0 112.375 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -47.29 -45.14 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.959 1.703 . . . . 0.0 111.917 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.3 m -61.28 -35.25 76.79 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.068 0.947 . . . . 0.0 112.429 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -89.71 -47.83 7.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.697 0.799 . . . . 0.0 110.909 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 CA--C 1.53 0.192 0 C-N-CA 124.858 1.263 . . . . 0.0 109.607 -177.574 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.9 m . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.92 155.04 35.04 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.351 2.7 . . . . 0.0 113.685 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.01 -33.8 67.54 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.961 1.304 . . . . 0.0 112.797 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.66 -38.35 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.293 1.437 . . . . 0.0 111.925 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 m -64.3 -31.99 73.41 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 CA--C 1.531 0.223 0 C-N-CA 123.232 0.613 . . . . 0.0 110.049 -176.69 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.9 m . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.03 167.95 25.9 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.319 2.679 . . . . 0.0 111.859 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -54.21 -37.85 65.01 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.844 1.258 . . . . 0.0 111.805 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.4 t -54.51 -43.47 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.035 1.334 . . . . 0.0 111.006 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.4 m -71.58 -21.12 61.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.72 -48.14 7.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.286 0.634 . . . . 0.0 110.555 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.9 m . . . . . 0 CA--C 1.53 0.205 0 C-N-CA 124.923 1.289 . . . . 0.0 109.495 -178.821 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.0 m . . . . . 0 CA--C 1.534 0.345 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.68 144.02 44.5 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.253 2.636 . . . . 0.0 112.798 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.49 -40.93 65.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.385 1.074 . . . . 0.0 112.478 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -52.93 -31.71 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.091 1.357 . . . . 0.0 112.72 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.4 m -58.0 -44.75 87.38 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.359 1.064 . . . . 0.0 111.034 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 N--CA 1.454 -0.244 0 C-N-CA 123.953 0.901 . . . . 0.0 110.28 -174.21 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.7 m . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -49.84 145.18 18.96 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.543 2.829 . . . . 0.0 113.744 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.59 -38.71 67.05 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.049 0.94 . . . . 0.0 111.412 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.9 t -51.33 -35.35 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.832 1.653 . . . . 0.0 112.076 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.9 m -50.96 -48.2 61.05 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.814 0.846 . . . . 0.0 110.785 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -89.58 -48.6 7.19 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.299 1.04 . . . . 0.0 109.593 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 124.747 1.219 . . . . 0.0 107.891 175.625 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.8 m . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -65.87 141.62 65.85 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.258 1.972 . . . . 0.0 111.743 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.56 53.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.672 1.589 . . . . 0.0 113.211 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.96 -31.92 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.719 1.207 . . . . 0.0 112.598 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.6 m -64.2 -36.77 85.15 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.085 0.554 . . . . 0.0 111.959 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 . . . . . 0 N--CA 1.455 -0.176 0 C-N-CA 123.805 0.842 . . . . 0.0 109.765 -177.255 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.08 163.86 37.77 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.383 2.722 . . . . 0.0 111.665 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.29 -44.57 54.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.78 1.632 . . . . 0.0 112.768 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.07 -31.4 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.807 1.243 . . . . 0.0 112.917 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.1 m -57.65 -42.72 84.02 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.152 0.581 . . . . 0.0 111.197 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -89.47 -48.77 7.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.956 0.902 . . . . 0.0 110.485 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.4 t . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 123.526 0.73 . . . . 0.0 110.461 -178.01 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.9 m . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.72 140.65 56.87 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.155 1.903 . . . . 0.0 112.018 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.65 -26.62 14.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.666 1.987 . . . . 0.0 114.483 -172.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.7 p -52.42 -32.21 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.81 0.844 . . . . 0.0 111.953 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.49 12.01 15.56 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 . . . . . 0 C--N 1.342 0.279 0 C-N-CA 126.084 1.754 . . . . 0.0 109.186 -177.818 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 92.4 m . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -52.72 147.47 31.36 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.353 2.702 . . . . 0.0 113.335 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -49.2 -43.01 41.96 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.031 1.332 . . . . 0.0 113.077 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -47.43 -35.51 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.303 1.441 . . . . 0.0 112.966 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.2 m -51.3 -46.99 62.72 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.243 1.017 . . . . 0.0 111.19 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -90.16 -47.15 7.99 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.976 1.31 . . . . 0.0 110.422 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.454 -0.232 0 C-N-CA 124.325 1.05 . . . . 0.0 108.988 179.202 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 90.4 m . . . . . 0 CA--C 1.536 0.429 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.07 157.06 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.404 2.736 . . . . 0.0 113.838 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.58 -38.14 66.35 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.684 1.194 . . . . 0.0 111.953 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.93 -36.1 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.191 1.796 . . . . 0.0 111.811 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.95 -31.46 72.71 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.649 0.78 . . . . 0.0 112.823 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 . . . . . 0 C--N 1.34 0.193 0 C-N-CA 124.33 1.052 . . . . 0.0 111.204 -172.009 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.475 ' N ' ' HH ' ' A' ' 20' ' ' TYR . 76.1 m . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.47 151.97 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.974 2.449 . . . . 0.0 113.36 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -53.41 -32.7 50.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.605 1.162 . . . . 0.0 112.368 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.0 t -51.94 -37.87 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.347 1.459 . . . . 0.0 111.309 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -59.6 -38.07 80.28 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.838 0.855 . . . . 0.0 112.148 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.475 ' HH ' ' N ' ' A' ' 15' ' ' CYS . 14.1 m-85 -98.56 -53.7 3.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.138 0.975 . . . . 0.0 110.809 -169.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 CA--C 1.533 0.298 0 C-N-CA 125.571 1.548 . . . . 0.0 109.952 -178.318 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.52 -45.36 87.56 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.949 0.899 . . . . 0.0 109.659 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 58.2 m -89.43 158.28 46.16 Favored Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 124.548 1.139 . . . . 0.0 108.075 176.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.21 146.42 69.76 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.193 1.929 . . . . 0.0 111.722 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.17 -41.02 59.89 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.57 1.548 . . . . 0.0 112.997 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -48.47 -38.01 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.515 1.526 . . . . 0.0 112.853 -177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.5 m -60.33 -36.59 78.3 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 124.325 1.05 . . . . 0.0 112.415 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -89.99 -56.86 3.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.132 0.973 . . . . 0.0 109.485 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.87 123.33 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 125.562 1.545 . . . . 0.0 108.63 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.45 -64.4 0.53 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.54 -124.13 2.5 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 170.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -138.1 -65.55 0.51 Allowed 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.366 1.066 . . . . 0.0 108.35 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.03 115.58 2.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -153.06 44.15 0.64 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.424 0.69 . . . . 0.0 110.4 -176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 m -139.84 160.7 59.79 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 126.099 1.76 . . . . 0.0 108.667 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.46 159.27 53.2 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.934 2.423 . . . . 0.0 110.664 172.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -51.28 -41.91 60.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.989 1.315 . . . . 0.0 112.735 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.8 t -51.92 -38.77 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.343 1.457 . . . . 0.0 112.191 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.0 m -55.53 -38.71 69.6 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.545 0.738 . . . . 0.0 111.836 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -89.45 -52.63 4.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.81 0.844 . . . . 0.0 109.209 -177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.6 t -83.12 73.01 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 124.631 1.172 . . . . 0.0 107.97 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.051 0 CA-C-N 116.447 -0.342 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.665 0 CA-C-O 119.791 -0.147 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 63.9 tp -91.79 -54.39 3.89 Favored 'General case' 0 C--N 1.34 0.164 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 77.5 m -89.86 177.07 2.61 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.936 1.294 . . . . 0.0 109.474 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -58.89 149.54 77.92 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.774 2.316 . . . . 0.0 112.166 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.0 -42.95 60.71 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.899 1.28 . . . . 0.0 113.136 -173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.3 p -53.33 -31.46 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.706 1.202 . . . . 0.0 112.907 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.6 m -55.04 -43.23 73.57 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.073 0.549 . . . . 0.0 111.072 176.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -89.87 -47.61 7.77 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.539 1.136 . . . . 0.0 109.735 -175.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.2 t -74.27 85.68 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 124.606 1.162 . . . . 0.0 108.197 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.76 58.58 1.6 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.406 1.003 . . . . 0.0 110.613 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.23 111.12 0.3 Allowed Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 176.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -76.78 -54.24 6.88 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 173.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.76 53.52 1.95 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.129 1.372 . . . . 0.0 108.687 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.68 -51.93 7.26 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 124.129 0.971 . . . . 0.0 109.031 -177.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 75.8 m -89.53 176.74 2.89 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.476 1.111 . . . . 0.0 108.828 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -58.02 151.88 55.03 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.409 2.073 . . . . 0.0 112.468 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -52.49 -40.38 62.29 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.713 1.205 . . . . 0.0 112.98 -172.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.1 p -49.17 -35.83 8.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.647 1.579 . . . . 0.0 112.423 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 84.8 m -52.75 -47.1 67.66 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.15 0.98 . . . . 0.0 111.066 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -89.74 -49.83 6.41 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.062 0.945 . . . . 0.0 110.816 -171.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.2 m -73.26 -32.23 37.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.002 0 O-C-N 121.893 -0.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -153.47 46.17 0.65 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.254 1.021 . . . . 0.0 109.926 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.6 m -136.24 156.59 76.67 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 124.987 1.315 . . . . 0.0 109.756 -176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.19 162.8 41.34 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.314 2.676 . . . . 0.0 110.684 172.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.28 -37.64 56.09 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.935 1.294 . . . . 0.0 112.754 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 80.0 t -51.33 -40.33 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.328 1.451 . . . . 0.0 111.901 -177.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.4 m -59.51 -36.77 76.71 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.552 0.741 . . . . 0.0 111.955 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -89.4 -53.06 4.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.734 0.814 . . . . 0.0 109.832 -176.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.6 t -125.14 89.76 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 125.452 1.501 . . . . 0.0 107.508 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 168.45 162.23 20.08 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.8 47.15 3.78 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 123.519 0.581 . . . . 0.0 112.689 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -162.43 70.77 0.3 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.369 1.068 . . . . 0.0 108.242 174.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.27 11.7 7.86 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.669 0.788 . . . . 0.0 112.119 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.7 mt -80.41 70.19 7.04 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.261 1.025 . . . . 0.0 108.668 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.3 m -131.06 162.01 58.21 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 125.272 1.429 . . . . 0.0 108.933 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -49.95 138.24 35.14 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.658 2.905 . . . . 0.0 113.497 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -56.51 -39.7 73.76 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.081 0.952 . . . . 0.0 111.813 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.2 t -52.21 -38.5 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.644 1.578 . . . . 0.0 111.448 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 89.4 m -55.31 -36.38 66.14 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.645 0.778 . . . . 0.0 112.249 178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -89.48 -50.77 5.9 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.913 0.885 . . . . 0.0 109.408 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.1 p -157.57 130.33 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 124.55 1.14 . . . . 0.0 108.873 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.042 0 O-C-N 122.011 -0.431 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.66 -44.7 77.23 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.512 0.725 . . . . 0.0 110.228 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.2 m -130.66 160.51 65.94 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 125.645 1.578 . . . . 0.0 108.749 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.4 158.64 51.59 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.843 2.362 . . . . 0.0 111.763 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.97 -41.45 62.13 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 125.156 1.382 . . . . 0.0 112.581 -176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.5 t -48.77 -47.74 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.981 1.312 . . . . 0.0 111.317 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.6 m -63.0 -22.43 66.85 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -89.35 -58.74 2.42 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.5 m -85.57 62.56 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.122 0.569 . . . . 0.0 109.956 175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.37 62.9 0.15 Allowed Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.642 1.115 . . . . 0.0 111.443 175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -170.82 86.81 0.08 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.754 -0.939 . . . . 0.0 110.754 175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -61.59 -50.3 73.16 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.306 0.643 . . . . 0.0 109.776 175.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.91 42.62 1.33 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.272 1.029 . . . . 0.0 109.934 176.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.08 -57.72 3.68 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 176.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 m -89.47 159.85 43.3 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 124.573 1.149 . . . . 0.0 108.99 172.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.77 156.84 64.1 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.166 2.578 . . . . 0.0 111.937 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.52 -21.99 66.84 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.799 1.239 . . . . 0.0 113.811 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -53.4 -36.23 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.562 0.745 . . . . 0.0 111.504 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 33.9 m -74.73 -26.19 59.63 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.567 0.747 . . . . 0.0 112.91 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -89.43 -54.15 4.22 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.416 0.553 . . . . 0.0 109.941 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.3 m -120.9 -34.81 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 125.394 1.477 . . . . 0.0 110.737 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.052 0 O-C-N 121.88 -0.512 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.22 -47.2 68.5 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.356 0.662 . . . . 0.0 110.08 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 15.6 m -128.5 160.92 60.04 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 125.199 1.4 . . . . 0.0 109.099 175.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.83 157.97 53.5 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.078 2.518 . . . . 0.0 112.009 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.24 -36.42 66.02 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 125.219 1.407 . . . . 0.0 113.392 -173.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.8 p -52.32 -39.39 27.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 124.299 1.04 . . . . 0.0 112.631 -177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.2 m -67.66 -27.99 67.33 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -89.78 -61.65 1.64 Allowed 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.498 0.719 . . . . 0.0 109.141 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.8 t -98.45 78.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.146 1.378 . . . . 0.0 107.593 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.79 156.74 9.86 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.56 -30.67 75.15 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.878 0.751 . . . . 0.0 112.312 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -79.12 67.47 4.84 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.33 1.052 . . . . 0.0 110.219 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.85 53.41 1.65 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.007 1.323 . . . . 0.0 110.439 177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.9 tt -93.46 66.7 3.93 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.719 1.208 . . . . 0.0 107.749 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.7 m -145.17 153.1 52.43 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 124.884 1.274 . . . . 0.0 108.449 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.35 165.61 32.17 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.468 2.779 . . . . 0.0 112.198 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -52.64 -45.53 66.72 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.673 1.189 . . . . 0.0 111.823 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -53.05 -40.82 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.833 1.253 . . . . 0.0 111.576 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.8 m -63.75 -26.22 68.54 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -89.52 -51.96 5.27 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.576 0.75 . . . . 0.0 109.019 177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.51 70.9 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.046 1.338 . . . . 0.0 108.089 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.045 0 O-C-N 122.067 -0.395 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 120.35 0.119 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.58 -47.31 41.49 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.829 0.852 . . . . 0.0 109.0 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.1 m -89.18 170.58 10.55 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 124.324 1.05 . . . . 0.0 108.568 173.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.01 153.4 20.79 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.906 2.404 . . . . 0.0 112.049 169.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.93 -37.59 45.12 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.914 1.286 . . . . 0.0 113.623 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.6 p -54.77 -31.17 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 124.199 1.0 . . . . 0.0 112.56 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 97.3 m -74.19 10.54 1.21 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.096 0.958 . . . . 0.0 113.053 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -137.99 -57.01 0.67 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.7 t -71.06 92.0 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 174.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.03 45.33 42.0 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -172.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -150.68 79.59 0.2 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -65.76 -61.48 2.05 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.336 0.654 . . . . 0.0 110.685 -177.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -160.64 73.03 0.48 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.815 0.846 . . . . 0.0 109.377 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -151.92 43.36 0.72 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.432 0.693 . . . . 0.0 110.947 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 97.3 m -147.0 166.06 17.36 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 126.5 1.92 . . . . 0.0 107.18 175.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.1 127.41 12.67 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.515 2.81 . . . . 0.0 113.174 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -48.35 -44.24 34.19 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 125.389 1.475 . . . . 0.0 112.973 -171.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 p -50.7 -34.39 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.964 1.306 . . . . 0.0 112.924 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.8 m -64.42 -29.97 71.01 Favored 'General case' 0 C--N 1.34 0.16 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -89.8 -54.66 3.95 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.866 0.866 . . . . 0.0 109.011 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.3 72.13 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.855 1.262 . . . . 0.0 108.202 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.044 0 O-C-N 122.1 -0.375 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 111.741 0.274 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.82 -47.84 76.55 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.843 0.857 . . . . 0.0 109.582 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 68.0 m -89.53 157.22 47.32 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 124.509 1.124 . . . . 0.0 108.346 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -68.14 153.21 75.33 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.375 2.05 . . . . 0.0 111.296 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -50.18 -38.23 38.75 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.339 1.456 . . . . 0.0 112.728 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 86.8 t -51.01 -37.91 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 125.317 1.447 . . . . 0.0 112.086 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 83.1 m -56.07 -42.06 76.08 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.075 0.95 . . . . 0.0 111.504 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -89.52 -52.96 4.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.035 0.934 . . . . 0.0 109.823 -173.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.9 t -135.87 107.14 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 125.141 1.376 . . . . 0.0 107.691 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.58 -69.73 0.09 OUTLIER Glycine 0 C--N 1.337 0.587 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 171.57 -53.69 0.18 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -80.95 71.99 7.94 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.787 0.835 . . . . 0.0 109.129 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.06 4.7 6.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.71 1.204 . . . . 0.0 112.734 175.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.64 71.21 5.09 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 63.2 m -126.08 158.86 64.75 Favored Pre-proline 0 CA--C 1.533 0.317 0 C-N-CA 125.566 1.547 . . . . 0.0 108.455 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.06 143.7 13.55 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.822 3.015 . . . . 0.0 113.524 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -56.0 -39.52 72.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.731 0.812 . . . . 0.0 111.776 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.2 p -56.74 -27.24 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.949 1.3 . . . . 0.0 112.807 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 76.6 m -51.78 -46.68 64.25 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.226 0.611 . . . . 0.0 110.358 174.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -89.78 -47.96 7.56 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.795 1.238 . . . . 0.0 109.478 -175.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 23.3 t -81.7 72.05 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.707 1.203 . . . . 0.0 108.04 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.063 0 O-C-N 122.119 -0.363 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 120.718 0.294 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -64.81 -33.75 76.72 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.258 0.623 . . . . 0.0 111.685 176.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 80.1 m -89.72 168.9 13.73 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.74 1.216 . . . . 0.0 108.661 174.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -52.18 140.99 50.11 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.344 2.696 . . . . 0.0 113.857 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.0 -35.09 61.49 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.13 1.372 . . . . 0.0 112.952 -175.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.84 -30.46 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.939 0.896 . . . . 0.0 112.133 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.5 m -77.17 24.06 0.18 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.508 0.723 . . . . 0.0 112.736 176.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -148.77 -55.56 0.2 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.3 t -75.48 85.26 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 172.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.73 56.12 3.67 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.0 85.31 0.08 OUTLIER Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.74 -45.26 75.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.726 0.811 . . . . 0.0 110.873 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.13 53.05 1.28 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.582 1.153 . . . . 0.0 108.836 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 63.9 tp -83.03 -41.13 19.03 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.343 1.057 . . . . 0.0 109.786 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.2 m -89.05 168.55 15.17 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.491 1.116 . . . . 0.0 109.157 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -62.57 151.5 82.94 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.424 2.083 . . . . 0.0 110.948 170.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -47.59 -40.96 20.66 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.116 1.766 . . . . 0.0 113.52 -173.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 p -46.12 -39.79 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 125.592 1.557 . . . . 0.0 112.791 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 93.7 m -60.17 -36.06 76.73 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.983 0.913 . . . . 0.0 112.14 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -89.28 -49.61 6.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.798 0.839 . . . . 0.0 110.46 -173.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.3 m -71.77 -33.9 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 117.799 0.272 . . . . 0.0 111.613 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.001 0 O-C-N 121.923 -0.485 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 119.458 -0.306 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.45 -56.61 5.14 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 37.4 m -103.67 166.32 11.93 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.203 1.801 . . . . 0.0 109.435 171.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -54.23 154.03 19.9 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.893 3.062 . . . . 0.0 113.855 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.35 -42.86 74.45 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.156 1.383 . . . . 0.0 113.039 -174.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -55.48 -34.33 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 124.468 1.107 . . . . 0.0 112.846 -175.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 30.0 m -65.71 -22.73 66.64 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -89.79 -51.28 5.58 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.3 t -82.28 73.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.648 1.179 . . . . 0.0 108.759 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.27 63.86 1.83 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 123.861 0.743 . . . . 0.0 111.929 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.34 44.69 0.09 OUTLIER Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 172.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -63.98 -8.87 12.83 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.367 1.467 . . . . 0.0 114.139 -169.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.73 37.71 1.82 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.878 0.763 . . . . 0.0 110.921 173.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.3 mt -97.47 -46.31 6.1 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 123.663 0.785 . . . . 0.0 109.355 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.2 m -89.43 162.45 36.76 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 123.926 0.89 . . . . 0.0 110.194 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -53.45 151.96 22.12 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.977 3.118 . . . . 0.0 113.893 174.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -55.4 -43.58 75.35 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.85 1.26 . . . . 0.0 112.804 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -55.13 -32.81 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.704 1.202 . . . . 0.0 112.98 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.2 m -64.96 -25.86 68.05 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.215 0.462 . . . . 0.0 112.241 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -89.56 -52.85 4.8 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.5 t -84.41 71.64 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.78 1.232 . . . . 0.0 108.151 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.08 0 CA-C-N 116.47 -0.332 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 111.713 0.264 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 70.7 mt -66.55 -53.34 35.79 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.103 0.561 . . . . 0.0 110.261 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 78.9 m -101.76 176.85 1.68 Allowed Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.882 1.273 . . . . 0.0 109.67 -178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -61.76 154.16 62.64 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.836 2.358 . . . . 0.0 112.313 176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.19 -41.48 68.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.679 1.192 . . . . 0.0 113.176 -173.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.0 p -51.12 -34.38 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.915 1.286 . . . . 0.0 112.545 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.9 m -56.21 -43.49 78.59 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.036 0.934 . . . . 0.0 111.175 178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -93.18 -58.23 2.38 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.561 1.144 . . . . 0.0 110.034 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.7 t -117.37 101.04 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.595 1.558 . . . . 0.0 107.061 -178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 174.41 -29.06 0.09 OUTLIER Glycine 0 CA--C 1.528 0.86 0 CA-C-O 119.568 -0.573 . . . . 0.0 112.328 -175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.18 -44.7 2.47 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -77.06 68.29 3.18 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.533 1.133 . . . . 0.0 109.179 175.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.32 39.63 0.53 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.002 1.321 . . . . 0.0 111.983 -176.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.7 mp -85.69 69.03 10.58 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.457 1.103 . . . . 0.0 108.186 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.8 m -139.93 152.18 67.2 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 125.074 1.35 . . . . 0.0 107.71 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.16 159.26 52.99 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.81 2.34 . . . . 0.0 112.31 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -52.42 -36.27 53.9 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 125.241 1.416 . . . . 0.0 112.239 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.1 t -46.86 -40.45 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.55 1.54 . . . . 0.0 111.596 178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.8 m -55.34 -45.56 76.4 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 124.103 0.961 . . . . 0.0 111.709 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -89.63 -37.48 14.61 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.376 1.07 . . . . 0.0 110.945 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 70.8 t -65.0 -49.3 80.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.969 0.907 . . . . 0.0 109.681 174.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.05 0 O-C-N 122.066 -0.396 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 111.387 0.143 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.8 mp -73.52 -5.78 42.29 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.342 1.057 . . . . 0.0 112.704 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.0 m -89.28 164.76 29.08 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 118.927 0.785 . . . . 0.0 110.198 -173.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -58.58 152.39 55.82 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.423 2.748 . . . . 0.0 114.22 -175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.62 -41.23 76.73 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.296 1.038 . . . . 0.0 111.036 173.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.0 t -51.15 -44.01 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 125.118 1.367 . . . . 0.0 110.769 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 54.1 m -65.69 -20.02 66.13 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -89.44 -21.85 22.8 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.452 0.569 . . . . 0.0 110.94 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 83.9 t -71.8 108.68 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.04 -41.38 10.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.681 1.61 . . . . 0.0 113.497 -177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -50.36 -34.75 26.78 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.993 1.282 . . . . 0.0 113.606 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -140.31 63.38 1.47 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.8 0.8 . . . . 0.0 108.951 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.13 58.29 2.95 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.802 0.841 . . . . 0.0 110.908 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.99 59.91 4.2 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.187 0.995 . . . . 0.0 110.607 -169.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.8 m -143.74 155.37 59.77 Favored Pre-proline 0 CA--C 1.534 0.354 0 C-N-CA 124.643 1.177 . . . . 0.0 108.277 169.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -60.73 164.44 13.67 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.966 2.444 . . . . 0.0 113.02 173.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -55.68 -31.36 62.33 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.039 1.336 . . . . 0.0 113.24 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.8 p -49.26 -41.44 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 125.095 1.358 . . . . 0.0 112.055 -177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 99.3 m -61.07 -34.33 74.74 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.483 1.113 . . . . 0.0 111.868 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -91.97 -48.53 6.71 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.299 1.039 . . . . 0.0 110.505 -170.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.53 -37.74 71.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.871 0.468 . . . . 0.0 110.942 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.063 0 O-C-N 121.89 -0.506 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.1 72.1 6.88 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.069 0.948 . . . . 0.0 108.921 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 63.3 m -137.26 154.57 75.7 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 125.453 1.501 . . . . 0.0 108.257 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.64 149.63 79.29 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.83 2.354 . . . . 0.0 111.578 -177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.76 -42.71 65.22 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.284 1.434 . . . . 0.0 112.753 -174.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -54.56 -34.38 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.462 1.105 . . . . 0.0 112.699 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 22.2 m -65.9 -26.42 67.61 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -89.42 -56.36 3.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 174.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.0 t -82.59 73.29 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 124.737 1.215 . . . . 0.0 108.075 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.59 -57.61 0.04 OUTLIER Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -167.14 -119.03 0.46 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 176.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -119.3 -99.26 0.44 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.394 1.078 . . . . 0.0 109.232 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.98 66.69 9.31 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.763 0.825 . . . . 0.0 111.38 -172.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mp -81.81 -58.45 2.99 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.5 m -89.52 169.36 12.9 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 124.628 1.171 . . . . 0.0 107.841 169.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -55.97 161.25 8.78 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.293 2.662 . . . . 0.0 114.126 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.34 -39.58 70.19 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.08 1.352 . . . . 0.0 113.452 -172.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -53.47 -31.52 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.018 1.327 . . . . 0.0 112.983 -174.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.0 m -52.66 -46.45 67.18 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.22 1.008 . . . . 0.0 111.14 177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -91.36 -47.4 7.49 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.906 1.283 . . . . 0.0 108.867 -174.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.56 72.34 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.931 1.292 . . . . 0.0 107.967 176.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.061 0 O-C-N 122.089 -0.382 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.7 mt -68.16 -43.54 77.98 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.48 0.712 . . . . 0.0 110.163 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.5 m -134.09 160.6 67.89 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 125.84 1.656 . . . . 0.0 108.52 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.93 163.87 35.85 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.852 2.368 . . . . 0.0 112.133 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.52 -39.9 71.11 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.661 1.184 . . . . 0.0 111.746 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.2 t -51.87 -47.49 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 124.459 1.103 . . . . 0.0 110.397 177.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.5 m -66.65 -16.64 64.35 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -93.46 -12.99 28.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.701 0.801 . . . . 0.0 112.144 174.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.0 t -70.59 112.37 5.35 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 107.065 -1.458 . . . . 0.0 107.065 169.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.18 86.43 0.06 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.06 1.314 . . . . 0.0 110.561 178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 158.11 -46.82 0.46 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -171.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -105.12 34.92 3.0 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.765 1.226 . . . . 0.0 109.607 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.31 70.04 8.07 Favored 'General case' 0 C--N 1.341 0.225 0 C-N-CA 124.357 1.063 . . . . 0.0 110.485 -174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 77.3 mt -108.07 54.09 0.67 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.484 1.114 . . . . 0.0 110.559 -173.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 66.9 m -139.53 160.64 60.72 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.172 0.989 . . . . 0.0 109.353 173.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -56.08 152.19 38.63 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.319 2.679 . . . . 0.0 113.707 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -59.06 -22.52 60.88 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.653 1.181 . . . . 0.0 112.596 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.0 t -52.13 -46.22 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.832 1.253 . . . . 0.0 110.703 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.7 m -66.22 -29.56 69.84 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.362 0.665 . . . . 0.0 112.496 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -89.71 -35.15 15.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.782 0.833 . . . . 0.0 111.26 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.3 p -152.15 -42.75 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 124.71 1.204 . . . . 0.0 110.485 -177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 -0.01 0 O-C-N 121.8 -0.562 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.688 0 CA-C-O 120.655 0.264 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.85 -36.85 80.18 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.408 0.683 . . . . 0.0 112.045 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 52.1 m -107.44 169.27 6.89 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 125.144 1.377 . . . . 0.0 108.847 171.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.56 143.39 68.21 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.519 2.812 . . . . 0.0 114.081 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.02 -39.73 82.79 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.692 1.197 . . . . 0.0 112.373 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.52 -32.16 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.714 1.206 . . . . 0.0 112.361 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -61.4 -34.49 75.45 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.794 0.438 . . . . 0.0 111.95 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -89.46 -49.94 6.39 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.437 0.695 . . . . 0.0 109.406 -177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 p -122.47 80.98 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.244 1.418 . . . . 0.0 108.95 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.98 156.54 9.79 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.236 -1.145 . . . . 0.0 110.236 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -83.38 53.98 4.91 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -161.41 78.22 0.56 Allowed 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.57 43.57 0.67 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.505 1.122 . . . . 0.0 111.368 -178.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 34.1 tp -87.71 71.83 9.57 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.392 1.077 . . . . 0.0 108.771 -174.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 m -148.51 140.8 14.77 Favored Pre-proline 0 CA--C 1.533 0.303 0 C-N-CA 124.438 1.095 . . . . 0.0 109.327 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -51.75 162.95 1.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 124.218 3.278 . . . . 0.0 114.243 169.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -55.87 -47.8 76.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.959 1.304 . . . . 0.0 112.306 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -56.4 -28.73 26.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.758 1.223 . . . . 0.0 112.955 -176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.6 m -58.78 -35.45 72.83 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 123.289 0.635 . . . . 0.0 111.532 176.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -89.36 -58.07 2.66 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.916 0.887 . . . . 0.0 109.043 -178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 9.5 m -92.13 66.66 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-O 121.668 0.746 . . . . 0.0 109.084 176.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 -0.05 0 CA-C-N 116.197 -0.456 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.8 tp -73.36 -57.15 4.21 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 174.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 61.3 m -89.96 -177.28 0.77 Allowed Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.877 1.271 . . . . 0.0 108.394 174.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -55.08 136.9 75.08 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.796 2.331 . . . . 0.0 112.918 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.02 -41.67 59.96 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.327 1.451 . . . . 0.0 113.193 -173.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.5 p -51.93 -34.37 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 124.812 1.245 . . . . 0.0 112.77 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.6 m -59.87 -36.04 76.08 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.199 0.6 . . . . 0.0 112.003 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -89.78 -46.48 8.56 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.3 t -85.17 82.44 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.682 1.193 . . . . 0.0 108.854 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.14 -55.07 0.56 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.848 0.737 . . . . 0.0 112.896 169.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.18 62.24 4.28 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-N 117.61 0.705 . . . . 0.0 112.071 -172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -51.82 -24.42 6.05 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.189 1.795 . . . . 0.0 115.362 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.23 37.49 3.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.881 0.872 . . . . 0.0 110.761 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -82.64 -46.0 13.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.5 m -88.75 161.65 41.02 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 123.989 0.916 . . . . 0.0 109.226 177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.54 167.42 24.21 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.931 2.421 . . . . 0.0 111.013 172.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -52.27 -40.83 62.25 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.995 1.318 . . . . 0.0 112.375 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -47.29 -45.14 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.959 1.703 . . . . 0.0 111.917 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.3 m -61.28 -35.25 76.79 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.068 0.947 . . . . 0.0 112.429 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -89.71 -47.83 7.67 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.697 0.799 . . . . 0.0 110.909 -174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.77 146.88 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 124.858 1.263 . . . . 0.0 109.607 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.09 0 O-C-N 122.114 -0.366 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.19 -62.46 1.53 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.833 0.853 . . . . 0.0 110.01 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 95.9 m -102.12 166.04 12.82 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.558 1.143 . . . . 0.0 109.184 171.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.92 155.04 35.04 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.351 2.7 . . . . 0.0 113.685 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.01 -33.8 67.54 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.961 1.304 . . . . 0.0 112.797 -178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.1 t -52.66 -38.35 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.293 1.437 . . . . 0.0 111.925 -177.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 m -64.3 -31.99 73.41 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -91.78 -56.0 3.26 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.232 0.613 . . . . 0.0 110.049 -176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 m -127.07 64.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 C-N-CA 125.76 1.624 . . . . 0.0 109.516 -172.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.3 -67.92 0.01 OUTLIER Glycine 0 C--N 1.337 0.594 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 161.18 -46.13 0.39 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.859 -0.497 . . . . 0.0 111.859 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -79.16 73.41 5.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.181 0.992 . . . . 0.0 109.447 -176.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.46 59.33 0.8 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.899 1.679 . . . . 0.0 110.92 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.9 mt -101.99 55.04 0.8 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.584 1.554 . . . . 0.0 108.172 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.9 m -132.4 153.87 81.37 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 125.03 1.332 . . . . 0.0 109.099 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.03 167.95 25.9 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.319 2.679 . . . . 0.0 111.859 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -54.21 -37.85 65.01 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.844 1.258 . . . . 0.0 111.805 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 92.4 t -54.51 -43.47 64.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.035 1.334 . . . . 0.0 111.006 -178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 32.4 m -71.58 -21.12 61.91 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -89.72 -48.14 7.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.286 0.634 . . . . 0.0 110.555 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.9 m -138.57 146.03 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.923 1.289 . . . . 0.0 109.495 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.084 0 O-C-N 122.101 -0.375 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.0 tp -61.04 -47.91 84.21 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.872 0.869 . . . . 0.0 110.145 177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.0 m -140.26 164.56 36.38 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.979 1.311 . . . . 0.0 108.277 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.68 144.02 44.5 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.253 2.636 . . . . 0.0 112.798 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.49 -40.93 65.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.385 1.074 . . . . 0.0 112.478 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.8 p -52.93 -31.71 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.091 1.357 . . . . 0.0 112.72 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 81.4 m -58.0 -44.75 87.38 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.359 1.064 . . . . 0.0 111.034 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -89.66 -53.56 4.46 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.953 0.901 . . . . 0.0 110.28 -174.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.3 t -131.74 103.23 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 124.991 1.317 . . . . 0.0 107.683 -177.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.27 -71.74 0.1 OUTLIER Glycine 0 C--N 1.337 0.612 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 176.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 168.55 -49.13 0.23 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.587 -0.605 . . . . 0.0 111.587 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -77.63 72.64 4.18 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.369 1.068 . . . . 0.0 109.616 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.34 4.94 5.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.733 1.213 . . . . 0.0 112.615 173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.5 mt -76.96 71.4 3.46 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 124.455 1.102 . . . . 0.0 109.024 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.7 m -130.77 160.34 66.96 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.718 1.607 . . . . 0.0 108.4 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -49.84 145.18 18.96 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.543 2.829 . . . . 0.0 113.744 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -54.59 -38.71 67.05 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.049 0.94 . . . . 0.0 111.412 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.9 t -51.33 -35.35 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.832 1.653 . . . . 0.0 112.076 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.9 m -50.96 -48.2 61.05 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.814 0.846 . . . . 0.0 110.785 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -89.58 -48.6 7.19 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.299 1.04 . . . . 0.0 109.593 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 22.1 t -82.0 72.24 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 124.747 1.219 . . . . 0.0 107.891 175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.078 0 O-C-N 122.048 -0.407 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -62.92 -39.35 94.3 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.565 0.746 . . . . 0.0 111.852 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 54.8 m -89.98 157.95 45.15 Favored Pre-proline 0 CA--C 1.536 0.424 0 C-N-CA 124.714 1.205 . . . . 0.0 107.869 172.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -65.87 141.62 65.85 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.258 1.972 . . . . 0.0 111.743 -173.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.56 53.15 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.672 1.589 . . . . 0.0 113.211 -173.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.9 p -53.96 -31.92 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.719 1.207 . . . . 0.0 112.598 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.6 m -64.2 -36.77 85.15 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 123.085 0.554 . . . . 0.0 111.959 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -89.8 -56.46 3.23 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.805 0.842 . . . . 0.0 109.765 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.2 m -124.3 73.59 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 125.736 1.614 . . . . 0.0 109.232 -173.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.58 -70.67 0.03 OUTLIER Glycine 0 C--N 1.337 0.605 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.59 -37.58 0.67 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -77.59 74.26 4.15 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.362 1.065 . . . . 0.0 109.154 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.31 42.54 0.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.269 1.828 . . . . 0.0 112.352 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.2 tp -86.3 69.44 10.44 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 13.3 m -145.83 143.8 20.58 Favored Pre-proline 0 N--CA 1.453 -0.308 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.08 163.86 37.77 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.383 2.722 . . . . 0.0 111.665 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -50.29 -44.57 54.0 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.78 1.632 . . . . 0.0 112.768 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 p -54.07 -31.4 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.807 1.243 . . . . 0.0 112.917 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.1 m -57.65 -42.72 84.02 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 123.152 0.581 . . . . 0.0 111.197 176.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -89.47 -48.77 7.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.956 0.902 . . . . 0.0 110.485 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 99.4 t -71.26 -46.1 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 123.526 0.73 . . . . 0.0 110.461 -178.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.074 0 O-C-N 121.932 -0.48 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.383 0.135 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 8.5 mp -64.23 -46.74 82.5 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.956 0.902 . . . . 0.0 109.689 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 56.9 m -89.73 164.2 29.89 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.631 1.572 . . . . 0.0 107.621 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -66.72 140.65 56.87 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.155 1.903 . . . . 0.0 112.018 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -52.65 -26.62 14.24 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.666 1.987 . . . . 0.0 114.483 -172.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.7 p -52.42 -32.21 16.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.81 0.844 . . . . 0.0 111.953 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 t -88.49 12.01 15.56 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -124.22 -44.8 2.0 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 126.084 1.754 . . . . 0.0 109.186 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.3 m -123.86 142.81 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 125.566 1.546 . . . . 0.0 108.095 177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 80.63 -75.57 2.22 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -170.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.85 75.47 2.35 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 107.138 -2.385 . . . . 0.0 107.138 169.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -35.42 -59.74 0.52 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.515 1.926 . . . . 0.0 114.251 -169.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.73 115.39 2.74 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -163.18 33.05 0.09 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.709 0.804 . . . . 0.0 112.018 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 92.4 m -130.45 163.19 49.85 Favored Pre-proline 0 CA--C 1.534 0.364 0 C-N-CA 124.687 1.195 . . . . 0.0 108.964 175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -52.72 147.47 31.36 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.353 2.702 . . . . 0.0 113.335 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -49.2 -43.01 41.96 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.031 1.332 . . . . 0.0 113.077 -172.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -47.43 -35.51 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.303 1.441 . . . . 0.0 112.966 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.2 m -51.3 -46.99 62.72 Favored 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.243 1.017 . . . . 0.0 111.19 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -90.16 -47.15 7.99 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.976 1.31 . . . . 0.0 110.422 -172.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.5 p -154.63 132.26 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 124.325 1.05 . . . . 0.0 108.988 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.078 0 O-C-N 122.038 -0.414 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.6 tp -62.1 -60.99 2.79 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.065 0.946 . . . . 0.0 109.99 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 90.4 m -106.9 165.76 12.3 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 125.43 1.492 . . . . 0.0 109.14 173.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -57.07 157.06 21.91 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.404 2.736 . . . . 0.0 113.838 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -54.58 -38.14 66.35 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.684 1.194 . . . . 0.0 111.953 177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.2 t -47.93 -36.1 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 126.191 1.796 . . . . 0.0 111.811 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.1 m -64.95 -31.46 72.71 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.649 0.78 . . . . 0.0 112.823 -178.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -101.39 -45.71 5.23 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 124.33 1.052 . . . . 0.0 111.204 -172.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.17 139.33 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 125.679 1.592 . . . . 0.0 107.649 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.68 54.46 10.0 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.4 127.64 5.63 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 107.007 -2.437 . . . . 0.0 107.007 -168.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -112.39 -37.84 4.86 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.364 1.066 . . . . 0.0 111.308 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.34 91.96 3.19 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.665 1.186 . . . . 0.0 108.582 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -153.9 -28.75 0.13 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.707 0.803 . . . . 0.0 112.598 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 76.1 m -89.25 168.3 15.65 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 123.617 0.767 . . . . 0.0 109.028 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -54.47 151.97 28.38 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.974 2.449 . . . . 0.0 113.36 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -53.41 -32.7 50.86 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.605 1.162 . . . . 0.0 112.368 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.0 t -51.94 -37.87 22.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.347 1.459 . . . . 0.0 111.309 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.7 m -59.6 -38.07 80.28 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.838 0.855 . . . . 0.0 112.148 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -98.56 -53.7 3.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.138 0.975 . . . . 0.0 110.809 -169.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 21.7 m -129.7 42.56 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.571 1.548 . . . . 0.0 109.952 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 -0.072 0 O-C-N 121.664 -0.648 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_